User login
Motivating Employees: Going Beyond Monetary Rewards
An Approach to Urticaria
The avoidant psychotherapy patient
CASE: Unexplained panic
Mr. J, age 35, is a married, unemployed musician who presents for outpatient treatment for panic attacks. He experienced his first panic attack at his oldest son’s baptism 12 years ago, but does not know why it occurred at that moment. He rarely has panic attacks now, but wants to continue medication management. He denies depressive symptoms, saying, “I’m the most optimistic person in the world.” Mr. J tried several medications for his panic attacks before clonazepam, 2 mg/d, proved effective, but always has been vehemently opposed to antidepressants. Despite his insistence that he needs only medication management, Mr. J chooses to enroll in a resident-run psychotherapy clinic.
In sessions, Mr. J describes his father, who also has panic disorder, as a powerful figure who is physically and emotionally abusive, but also charismatic, charming, and “impossible not to love.” However, Mr. J felt his father was impossible to live with, and moved out at age 18 to marry his high school sweetheart. They have 3 children, ages 12, 10, and 8. Mr. J worked for his father at his construction company, but was not able to satisfy him or live up to his standards so he quit because he was tired of being cut down and emasculated.
Mr. J’s parents divorced 15 years ago after his mother had an affair with her husband’s friend. His father learned of the affair and threatened his wife with a handgun. Although Mr. J and his mother were close before her affair, he has been unable to forgive or empathize with her, and rarely speaks to her. Mr. J’s mother could not protect him from his father’s abuse, and later compounded her failure by abandoning her husband and son through her sexual affair. Growing up with a father he did not respect or get comfort from and sharing a common fear and alliance with his mother likely made it difficult for Mr. J to navigate his Oedipal phase,1 and made her abandonment even more painful.
When Mr. J was 6 years old, he was molested by one of his father’s friends. His father stabbed the man in the shoulder when he found out about the molestation and received probation. Although Mr. J knows he was molested, he does not remember it and has repressed most of his childhood.
The authors’ observations
I (JF) wanted to discuss with Mr. J why his first panic attack occurred during such a symbolic occasion. His panic could be the result of a struggle between a murderous wish toward his father and paternal protective instinct toward his son. The baptism placed his son in a highly vulnerable position, which reminded Mr. J of his own vulnerability and impotent rage toward his father. Anxiety often results when an individual has 2 opposing wishes,2 and a murderous wish often is involved when anxiety progresses to panic. Getting to the root of this with Mr. J could allow for further psychological growth.3 His murderous wishes and fantasies are ego-dystonic, and panic could be a way of punishing himself for these thoughts. When Mr. J identified himself as his son during the baptism, he likely was flooded with thoughts that his defenses were no longer able to repress. Seeing his son submerged in the baptismal font brought back an aspect of his own life that he had completely split off from consciousness, and likely will take time to process. Considering the current therapeutic dynamic, I decided that it was not the best time to address this potential conflict; however, I could have chosen a manualized form of psychodynamic psychotherapy for panic disorder.4 See Table 1 for an outline of the phases of psychodynamic psychotherapy for panic disorder.
Although Mr. J’s initial willingness to discuss his past was encouraging, he refused to schedule more than 1 session every 4 weeks. He also began to keep the content of our sessions superficial, which caused me angst because he seemed to be withholding information and would not come more frequently. Although I was not proud of my feelings, I had to be honest with myself that I had started to dislike Mr. J.
Table 1
Psychodynamic psychotherapy for panic disorder
| Phase | Comments |
|---|---|
| Treatment of acute panic | Therapy focuses on discovering the conscious and unconscious meaning of panic symptoms |
| Treatment of panic vulnerability | Core dynamic conflicts related to panic are understood and altered. Tasks include addressing the nature of the transference and working through them |
| Termination | The therapist directly addresses patients’ difficulties with separation and independence as they emerge in treatment. After treatment, patients may be better able to manage separations, anger, and independence |
| Source: Adapted from reference 4 | |
Countertransference reactions
Countertransference is a therapist's emotional reaction to a patient. Just as patients form reactions based on past relationships brought to present, therapists develop similar reactions.5 Noting one’s countertransference provides a window into how the patient’s thoughts and actions evoke feelings in others. It also can shed light on an aspect of the doctor-patient relationship that may have gone unnoticed.2
Countertransference hatred can occur when a therapist begins to dislike a patient. Typically, patients with borderline personality disorder, masochistic tendencies, or suicidality arouse strong countertransference reactions6; however, any patient can evoke these emotions. This type of hateful patient can precipitate antitherapeutic feelings such as aversion or malice that can be a major obstacle to treatment.7 Aversion leads the therapist to withdraw from the patient, and malice can trigger cruel impulses.
Maltsberger and Buie7 identified 5 defenses therapists may use to combat countertransference hatred (Table 2). When treating Mr. J, I used several of these defenses, including projection and turning against the self to protect myself from this challenging patient. In turning against the self, I became doubtful and critical of my skills and increasingly submissive to Mr. J. Additionally, I projected this countertransference hatred onto Mr. J, focusing on the negative transference that he brought to our therapeutic encounters. On an unconscious level, I may have feared retribution from Mr. J.
I became so frustrated with Mr. J that I reduced the frequency of our sessions to once every 6 weeks, which I realized could be evidence of my feelings regarding Mr. J’s minimization and avoidant style.
Table 2
Defenses against countertransference hate
| Defense mechanism | Description |
|---|---|
| Repression | Remaining unconscious of feelings of hate; may manifest as difficulty paying attention to what the patient is saying or feeling bored or tired |
| Turning against oneself | Doubting one’s capacity to help the patient; may feel inadequate, helpless, and hopeless. May lead to giving up on the patient because the therapist feels incompetent |
| Reaction formation | Turning hatred into the opposite emotion. The therapist may be too preoccupied with being helpful or overly concerned about the patient’s welfare and comfort |
| Projection | Feeling that the patient hates the therapist, leading to feelings of dread and fear |
| Distortion of reality | Devaluing the patient and seeing the patient as a hopeless case or a dangerous person. The therapist may feel indifference, pity, or anger toward the patient |
| Source: Reference 7 | |
TREATMENT: A breakthrough
Mr. J presents with obvious unease at the first visit after we had decreased the frequency of our sessions. At this point, Mr. J opens up to me. He says he has not been truthful with me, and has had worsening depression, anhedonia, and agoraphobia over the past year. He also reveals that he has homosexual fantasies that he cannot stop, which disturb him because he says he is heterosexual. He agrees to come once a week, and reluctantly admits that he desperately needs help.
Although Mr. J only takes clonazepam and citalopram, 20 mg/d, which I prescribed after he admitted to depression and anxiety, he has hyperlipidemia and a family history of heart disease. In addition to being a musician and working at his father’s construction company, he has worked as a security guard, bounty hunter, and computer technician. His careers have been solitary in nature, and, with the exception of computer work, permitted an outlet for aggression. However, he recently started taking online college classes and wants to become a music teacher because he feels he has a lot to offer children as a result of his life experiences. His fantasy of being a teacher shows considerably less aggression, and could be a sign of psychological growth.
Mr. J is struggling financially and his home is on the verge of foreclosure. Early in treatment he told me that he stopped paying his mortgage, but demonstrated blind optimism that things would “work out.” I asked if this was a wise decision, but he seemed confident and dismissive of my concerns. Although he now struggles with this situation, I consider this healthier than his constant pseudo-happy state, and a sign of psychological development.8 Despite his financial stressors, he wants to pursue his dream of being a famous musician, and says he “could never work a 9-to-5 job in a cubicle.”
The authors’ observations
I do not think it’s a coincidence that Mr. J stopped minimizing his symptoms when we decreased the frequency of his sessions. I had viewed our sessions as unproductive and blamed Mr. J for wasting both of our time with his resistance and minimization and had begun to dislike him. I felt impotent because he had been controlling each session with long, elaborate stories that had little relevance to his panic attacks, and I could not redirect him or get him to focus on pertinent issues. It was as if I was an audience for him, and provided nothing useful. However, I was interested in these superficial stories because Mr. J was charming and engaging. He likely reenacted his relationship with his father with me. Mr. J’s superficial relationship with me caused me to dislike him, and, similar to his father, reject him. This rejection likely was damaging because I was unable to anticipate his needs, which would have been to increase—rather than decrease—the frequency of our sessions. Just like his father, I was not able to take care of him.
Mr. J is deeply conflicted about his father. He states that his father “is a monster who instills fear and intimidation into everyone around him, but he’s charismatic, and I’ll always love him.” His view of his domineering father likely developed into a castration anxiety because he was afraid of competing for his mother’s love, contributing to a muddled sexual identity. This was intensified when Mr. J was sexually abused; he may have been stimulated by the molestation, adding to his confusion. Although Mr. J has repressed the abuse and split off most of his childhood, he suffers from shame, guilt, and depression because of his ego-dystonic homosexual fantasies. Homosexuality is at odds with his self-image and contributes to his anxiety and panic attacks. He cannot adequately discharge this dangerous libidinal energy, and as he becomes more conscious of it, his anxiety intensifies.
OUTCOME: Overcoming fear
As Mr. J sits crying in my office, he says he hasn’t cried in front of another man in years. I wonder aloud what his father would think of this situation. His states that his father does not respect any type of weakness and probably would “knock his teeth in.” Overcoming this fear of opening up will be a goal of Mr. J’s treatment. His unbridled optimism borders on pathologic, and is a defense against reality.8 Additionally, his reluctance to accept that he is suffering from depression, which he perceives as a weakness, will be a struggle throughout therapy. He likely will continue to minimize his symptoms when possible, making the true depths of his illness difficult to grasp.
Related Resources
- Waska R. Using countertransference: analytic contact, projective identification, and transference phantasy states. Am J Psychother. 2008;62(4):333-351.
- Gabbard GO, Litowitz BE, Williams P. Textbook of psychoanalysis. Arlington, VA: American Psychiatric Publishing, Inc; 2011.
Drug Brand Names
- Citalopram • Celexa
- Clonazepam • Klonopin
Disclosure
The authors report no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.
1. Blos P. Son and father: before and beyond the Oedipus complex. New York NY: Free Press/Macmillan; 1985.
2. Ursano RJ, Sonnenberg SM, Lazar SG. Concise guide to psychodynamic psychotherapy. Arlington VA: American Psychiatric Publishing; 2004.
3. Akhtar S. Comprehensive dictionary of psychoanalysis. London United Kingdom: Kamac Books; 2009.
4. Busch FN, Milrod BL, Singer MB. Theory and technique in psychodynamic treatment of panic disorder. J Psychother Pract Res. 1999;8(3):234-242.
5. Freud S. The future prospects of psycho-analytic therapy. The standard edition of the complete psychological works of Sigmund Freud volume XI (1910): five lectures on psycho-analysis, Leonardo da Vinci and other works. London, United Kingdom: Hogarth Press; 1957:139–152.
6. Winnicott DW. Hate in the counter-transference. J Psychother Pract Res. 1994;3(4):348-356.
7. Maltsberger JT, Buie DH. Countertransference hate in the treatment of suicidal patients. Arch Gen Psychiatry. 1974;30(5):625-633.
8. Akhtar S. “Someday…” and “if only…” fantasies: pathological optimism and inordinate nostalgia as related forms of idealization. J Am Psychoanal Assoc. 1996;44(3):723-753.
CASE: Unexplained panic
Mr. J, age 35, is a married, unemployed musician who presents for outpatient treatment for panic attacks. He experienced his first panic attack at his oldest son’s baptism 12 years ago, but does not know why it occurred at that moment. He rarely has panic attacks now, but wants to continue medication management. He denies depressive symptoms, saying, “I’m the most optimistic person in the world.” Mr. J tried several medications for his panic attacks before clonazepam, 2 mg/d, proved effective, but always has been vehemently opposed to antidepressants. Despite his insistence that he needs only medication management, Mr. J chooses to enroll in a resident-run psychotherapy clinic.
In sessions, Mr. J describes his father, who also has panic disorder, as a powerful figure who is physically and emotionally abusive, but also charismatic, charming, and “impossible not to love.” However, Mr. J felt his father was impossible to live with, and moved out at age 18 to marry his high school sweetheart. They have 3 children, ages 12, 10, and 8. Mr. J worked for his father at his construction company, but was not able to satisfy him or live up to his standards so he quit because he was tired of being cut down and emasculated.
Mr. J’s parents divorced 15 years ago after his mother had an affair with her husband’s friend. His father learned of the affair and threatened his wife with a handgun. Although Mr. J and his mother were close before her affair, he has been unable to forgive or empathize with her, and rarely speaks to her. Mr. J’s mother could not protect him from his father’s abuse, and later compounded her failure by abandoning her husband and son through her sexual affair. Growing up with a father he did not respect or get comfort from and sharing a common fear and alliance with his mother likely made it difficult for Mr. J to navigate his Oedipal phase,1 and made her abandonment even more painful.
When Mr. J was 6 years old, he was molested by one of his father’s friends. His father stabbed the man in the shoulder when he found out about the molestation and received probation. Although Mr. J knows he was molested, he does not remember it and has repressed most of his childhood.
The authors’ observations
I (JF) wanted to discuss with Mr. J why his first panic attack occurred during such a symbolic occasion. His panic could be the result of a struggle between a murderous wish toward his father and paternal protective instinct toward his son. The baptism placed his son in a highly vulnerable position, which reminded Mr. J of his own vulnerability and impotent rage toward his father. Anxiety often results when an individual has 2 opposing wishes,2 and a murderous wish often is involved when anxiety progresses to panic. Getting to the root of this with Mr. J could allow for further psychological growth.3 His murderous wishes and fantasies are ego-dystonic, and panic could be a way of punishing himself for these thoughts. When Mr. J identified himself as his son during the baptism, he likely was flooded with thoughts that his defenses were no longer able to repress. Seeing his son submerged in the baptismal font brought back an aspect of his own life that he had completely split off from consciousness, and likely will take time to process. Considering the current therapeutic dynamic, I decided that it was not the best time to address this potential conflict; however, I could have chosen a manualized form of psychodynamic psychotherapy for panic disorder.4 See Table 1 for an outline of the phases of psychodynamic psychotherapy for panic disorder.
Although Mr. J’s initial willingness to discuss his past was encouraging, he refused to schedule more than 1 session every 4 weeks. He also began to keep the content of our sessions superficial, which caused me angst because he seemed to be withholding information and would not come more frequently. Although I was not proud of my feelings, I had to be honest with myself that I had started to dislike Mr. J.
Table 1
Psychodynamic psychotherapy for panic disorder
| Phase | Comments |
|---|---|
| Treatment of acute panic | Therapy focuses on discovering the conscious and unconscious meaning of panic symptoms |
| Treatment of panic vulnerability | Core dynamic conflicts related to panic are understood and altered. Tasks include addressing the nature of the transference and working through them |
| Termination | The therapist directly addresses patients’ difficulties with separation and independence as they emerge in treatment. After treatment, patients may be better able to manage separations, anger, and independence |
| Source: Adapted from reference 4 | |
Countertransference reactions
Countertransference is a therapist's emotional reaction to a patient. Just as patients form reactions based on past relationships brought to present, therapists develop similar reactions.5 Noting one’s countertransference provides a window into how the patient’s thoughts and actions evoke feelings in others. It also can shed light on an aspect of the doctor-patient relationship that may have gone unnoticed.2
Countertransference hatred can occur when a therapist begins to dislike a patient. Typically, patients with borderline personality disorder, masochistic tendencies, or suicidality arouse strong countertransference reactions6; however, any patient can evoke these emotions. This type of hateful patient can precipitate antitherapeutic feelings such as aversion or malice that can be a major obstacle to treatment.7 Aversion leads the therapist to withdraw from the patient, and malice can trigger cruel impulses.
Maltsberger and Buie7 identified 5 defenses therapists may use to combat countertransference hatred (Table 2). When treating Mr. J, I used several of these defenses, including projection and turning against the self to protect myself from this challenging patient. In turning against the self, I became doubtful and critical of my skills and increasingly submissive to Mr. J. Additionally, I projected this countertransference hatred onto Mr. J, focusing on the negative transference that he brought to our therapeutic encounters. On an unconscious level, I may have feared retribution from Mr. J.
I became so frustrated with Mr. J that I reduced the frequency of our sessions to once every 6 weeks, which I realized could be evidence of my feelings regarding Mr. J’s minimization and avoidant style.
Table 2
Defenses against countertransference hate
| Defense mechanism | Description |
|---|---|
| Repression | Remaining unconscious of feelings of hate; may manifest as difficulty paying attention to what the patient is saying or feeling bored or tired |
| Turning against oneself | Doubting one’s capacity to help the patient; may feel inadequate, helpless, and hopeless. May lead to giving up on the patient because the therapist feels incompetent |
| Reaction formation | Turning hatred into the opposite emotion. The therapist may be too preoccupied with being helpful or overly concerned about the patient’s welfare and comfort |
| Projection | Feeling that the patient hates the therapist, leading to feelings of dread and fear |
| Distortion of reality | Devaluing the patient and seeing the patient as a hopeless case or a dangerous person. The therapist may feel indifference, pity, or anger toward the patient |
| Source: Reference 7 | |
TREATMENT: A breakthrough
Mr. J presents with obvious unease at the first visit after we had decreased the frequency of our sessions. At this point, Mr. J opens up to me. He says he has not been truthful with me, and has had worsening depression, anhedonia, and agoraphobia over the past year. He also reveals that he has homosexual fantasies that he cannot stop, which disturb him because he says he is heterosexual. He agrees to come once a week, and reluctantly admits that he desperately needs help.
Although Mr. J only takes clonazepam and citalopram, 20 mg/d, which I prescribed after he admitted to depression and anxiety, he has hyperlipidemia and a family history of heart disease. In addition to being a musician and working at his father’s construction company, he has worked as a security guard, bounty hunter, and computer technician. His careers have been solitary in nature, and, with the exception of computer work, permitted an outlet for aggression. However, he recently started taking online college classes and wants to become a music teacher because he feels he has a lot to offer children as a result of his life experiences. His fantasy of being a teacher shows considerably less aggression, and could be a sign of psychological growth.
Mr. J is struggling financially and his home is on the verge of foreclosure. Early in treatment he told me that he stopped paying his mortgage, but demonstrated blind optimism that things would “work out.” I asked if this was a wise decision, but he seemed confident and dismissive of my concerns. Although he now struggles with this situation, I consider this healthier than his constant pseudo-happy state, and a sign of psychological development.8 Despite his financial stressors, he wants to pursue his dream of being a famous musician, and says he “could never work a 9-to-5 job in a cubicle.”
The authors’ observations
I do not think it’s a coincidence that Mr. J stopped minimizing his symptoms when we decreased the frequency of his sessions. I had viewed our sessions as unproductive and blamed Mr. J for wasting both of our time with his resistance and minimization and had begun to dislike him. I felt impotent because he had been controlling each session with long, elaborate stories that had little relevance to his panic attacks, and I could not redirect him or get him to focus on pertinent issues. It was as if I was an audience for him, and provided nothing useful. However, I was interested in these superficial stories because Mr. J was charming and engaging. He likely reenacted his relationship with his father with me. Mr. J’s superficial relationship with me caused me to dislike him, and, similar to his father, reject him. This rejection likely was damaging because I was unable to anticipate his needs, which would have been to increase—rather than decrease—the frequency of our sessions. Just like his father, I was not able to take care of him.
Mr. J is deeply conflicted about his father. He states that his father “is a monster who instills fear and intimidation into everyone around him, but he’s charismatic, and I’ll always love him.” His view of his domineering father likely developed into a castration anxiety because he was afraid of competing for his mother’s love, contributing to a muddled sexual identity. This was intensified when Mr. J was sexually abused; he may have been stimulated by the molestation, adding to his confusion. Although Mr. J has repressed the abuse and split off most of his childhood, he suffers from shame, guilt, and depression because of his ego-dystonic homosexual fantasies. Homosexuality is at odds with his self-image and contributes to his anxiety and panic attacks. He cannot adequately discharge this dangerous libidinal energy, and as he becomes more conscious of it, his anxiety intensifies.
OUTCOME: Overcoming fear
As Mr. J sits crying in my office, he says he hasn’t cried in front of another man in years. I wonder aloud what his father would think of this situation. His states that his father does not respect any type of weakness and probably would “knock his teeth in.” Overcoming this fear of opening up will be a goal of Mr. J’s treatment. His unbridled optimism borders on pathologic, and is a defense against reality.8 Additionally, his reluctance to accept that he is suffering from depression, which he perceives as a weakness, will be a struggle throughout therapy. He likely will continue to minimize his symptoms when possible, making the true depths of his illness difficult to grasp.
Related Resources
- Waska R. Using countertransference: analytic contact, projective identification, and transference phantasy states. Am J Psychother. 2008;62(4):333-351.
- Gabbard GO, Litowitz BE, Williams P. Textbook of psychoanalysis. Arlington, VA: American Psychiatric Publishing, Inc; 2011.
Drug Brand Names
- Citalopram • Celexa
- Clonazepam • Klonopin
Disclosure
The authors report no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.
CASE: Unexplained panic
Mr. J, age 35, is a married, unemployed musician who presents for outpatient treatment for panic attacks. He experienced his first panic attack at his oldest son’s baptism 12 years ago, but does not know why it occurred at that moment. He rarely has panic attacks now, but wants to continue medication management. He denies depressive symptoms, saying, “I’m the most optimistic person in the world.” Mr. J tried several medications for his panic attacks before clonazepam, 2 mg/d, proved effective, but always has been vehemently opposed to antidepressants. Despite his insistence that he needs only medication management, Mr. J chooses to enroll in a resident-run psychotherapy clinic.
In sessions, Mr. J describes his father, who also has panic disorder, as a powerful figure who is physically and emotionally abusive, but also charismatic, charming, and “impossible not to love.” However, Mr. J felt his father was impossible to live with, and moved out at age 18 to marry his high school sweetheart. They have 3 children, ages 12, 10, and 8. Mr. J worked for his father at his construction company, but was not able to satisfy him or live up to his standards so he quit because he was tired of being cut down and emasculated.
Mr. J’s parents divorced 15 years ago after his mother had an affair with her husband’s friend. His father learned of the affair and threatened his wife with a handgun. Although Mr. J and his mother were close before her affair, he has been unable to forgive or empathize with her, and rarely speaks to her. Mr. J’s mother could not protect him from his father’s abuse, and later compounded her failure by abandoning her husband and son through her sexual affair. Growing up with a father he did not respect or get comfort from and sharing a common fear and alliance with his mother likely made it difficult for Mr. J to navigate his Oedipal phase,1 and made her abandonment even more painful.
When Mr. J was 6 years old, he was molested by one of his father’s friends. His father stabbed the man in the shoulder when he found out about the molestation and received probation. Although Mr. J knows he was molested, he does not remember it and has repressed most of his childhood.
The authors’ observations
I (JF) wanted to discuss with Mr. J why his first panic attack occurred during such a symbolic occasion. His panic could be the result of a struggle between a murderous wish toward his father and paternal protective instinct toward his son. The baptism placed his son in a highly vulnerable position, which reminded Mr. J of his own vulnerability and impotent rage toward his father. Anxiety often results when an individual has 2 opposing wishes,2 and a murderous wish often is involved when anxiety progresses to panic. Getting to the root of this with Mr. J could allow for further psychological growth.3 His murderous wishes and fantasies are ego-dystonic, and panic could be a way of punishing himself for these thoughts. When Mr. J identified himself as his son during the baptism, he likely was flooded with thoughts that his defenses were no longer able to repress. Seeing his son submerged in the baptismal font brought back an aspect of his own life that he had completely split off from consciousness, and likely will take time to process. Considering the current therapeutic dynamic, I decided that it was not the best time to address this potential conflict; however, I could have chosen a manualized form of psychodynamic psychotherapy for panic disorder.4 See Table 1 for an outline of the phases of psychodynamic psychotherapy for panic disorder.
Although Mr. J’s initial willingness to discuss his past was encouraging, he refused to schedule more than 1 session every 4 weeks. He also began to keep the content of our sessions superficial, which caused me angst because he seemed to be withholding information and would not come more frequently. Although I was not proud of my feelings, I had to be honest with myself that I had started to dislike Mr. J.
Table 1
Psychodynamic psychotherapy for panic disorder
| Phase | Comments |
|---|---|
| Treatment of acute panic | Therapy focuses on discovering the conscious and unconscious meaning of panic symptoms |
| Treatment of panic vulnerability | Core dynamic conflicts related to panic are understood and altered. Tasks include addressing the nature of the transference and working through them |
| Termination | The therapist directly addresses patients’ difficulties with separation and independence as they emerge in treatment. After treatment, patients may be better able to manage separations, anger, and independence |
| Source: Adapted from reference 4 | |
Countertransference reactions
Countertransference is a therapist's emotional reaction to a patient. Just as patients form reactions based on past relationships brought to present, therapists develop similar reactions.5 Noting one’s countertransference provides a window into how the patient’s thoughts and actions evoke feelings in others. It also can shed light on an aspect of the doctor-patient relationship that may have gone unnoticed.2
Countertransference hatred can occur when a therapist begins to dislike a patient. Typically, patients with borderline personality disorder, masochistic tendencies, or suicidality arouse strong countertransference reactions6; however, any patient can evoke these emotions. This type of hateful patient can precipitate antitherapeutic feelings such as aversion or malice that can be a major obstacle to treatment.7 Aversion leads the therapist to withdraw from the patient, and malice can trigger cruel impulses.
Maltsberger and Buie7 identified 5 defenses therapists may use to combat countertransference hatred (Table 2). When treating Mr. J, I used several of these defenses, including projection and turning against the self to protect myself from this challenging patient. In turning against the self, I became doubtful and critical of my skills and increasingly submissive to Mr. J. Additionally, I projected this countertransference hatred onto Mr. J, focusing on the negative transference that he brought to our therapeutic encounters. On an unconscious level, I may have feared retribution from Mr. J.
I became so frustrated with Mr. J that I reduced the frequency of our sessions to once every 6 weeks, which I realized could be evidence of my feelings regarding Mr. J’s minimization and avoidant style.
Table 2
Defenses against countertransference hate
| Defense mechanism | Description |
|---|---|
| Repression | Remaining unconscious of feelings of hate; may manifest as difficulty paying attention to what the patient is saying or feeling bored or tired |
| Turning against oneself | Doubting one’s capacity to help the patient; may feel inadequate, helpless, and hopeless. May lead to giving up on the patient because the therapist feels incompetent |
| Reaction formation | Turning hatred into the opposite emotion. The therapist may be too preoccupied with being helpful or overly concerned about the patient’s welfare and comfort |
| Projection | Feeling that the patient hates the therapist, leading to feelings of dread and fear |
| Distortion of reality | Devaluing the patient and seeing the patient as a hopeless case or a dangerous person. The therapist may feel indifference, pity, or anger toward the patient |
| Source: Reference 7 | |
TREATMENT: A breakthrough
Mr. J presents with obvious unease at the first visit after we had decreased the frequency of our sessions. At this point, Mr. J opens up to me. He says he has not been truthful with me, and has had worsening depression, anhedonia, and agoraphobia over the past year. He also reveals that he has homosexual fantasies that he cannot stop, which disturb him because he says he is heterosexual. He agrees to come once a week, and reluctantly admits that he desperately needs help.
Although Mr. J only takes clonazepam and citalopram, 20 mg/d, which I prescribed after he admitted to depression and anxiety, he has hyperlipidemia and a family history of heart disease. In addition to being a musician and working at his father’s construction company, he has worked as a security guard, bounty hunter, and computer technician. His careers have been solitary in nature, and, with the exception of computer work, permitted an outlet for aggression. However, he recently started taking online college classes and wants to become a music teacher because he feels he has a lot to offer children as a result of his life experiences. His fantasy of being a teacher shows considerably less aggression, and could be a sign of psychological growth.
Mr. J is struggling financially and his home is on the verge of foreclosure. Early in treatment he told me that he stopped paying his mortgage, but demonstrated blind optimism that things would “work out.” I asked if this was a wise decision, but he seemed confident and dismissive of my concerns. Although he now struggles with this situation, I consider this healthier than his constant pseudo-happy state, and a sign of psychological development.8 Despite his financial stressors, he wants to pursue his dream of being a famous musician, and says he “could never work a 9-to-5 job in a cubicle.”
The authors’ observations
I do not think it’s a coincidence that Mr. J stopped minimizing his symptoms when we decreased the frequency of his sessions. I had viewed our sessions as unproductive and blamed Mr. J for wasting both of our time with his resistance and minimization and had begun to dislike him. I felt impotent because he had been controlling each session with long, elaborate stories that had little relevance to his panic attacks, and I could not redirect him or get him to focus on pertinent issues. It was as if I was an audience for him, and provided nothing useful. However, I was interested in these superficial stories because Mr. J was charming and engaging. He likely reenacted his relationship with his father with me. Mr. J’s superficial relationship with me caused me to dislike him, and, similar to his father, reject him. This rejection likely was damaging because I was unable to anticipate his needs, which would have been to increase—rather than decrease—the frequency of our sessions. Just like his father, I was not able to take care of him.
Mr. J is deeply conflicted about his father. He states that his father “is a monster who instills fear and intimidation into everyone around him, but he’s charismatic, and I’ll always love him.” His view of his domineering father likely developed into a castration anxiety because he was afraid of competing for his mother’s love, contributing to a muddled sexual identity. This was intensified when Mr. J was sexually abused; he may have been stimulated by the molestation, adding to his confusion. Although Mr. J has repressed the abuse and split off most of his childhood, he suffers from shame, guilt, and depression because of his ego-dystonic homosexual fantasies. Homosexuality is at odds with his self-image and contributes to his anxiety and panic attacks. He cannot adequately discharge this dangerous libidinal energy, and as he becomes more conscious of it, his anxiety intensifies.
OUTCOME: Overcoming fear
As Mr. J sits crying in my office, he says he hasn’t cried in front of another man in years. I wonder aloud what his father would think of this situation. His states that his father does not respect any type of weakness and probably would “knock his teeth in.” Overcoming this fear of opening up will be a goal of Mr. J’s treatment. His unbridled optimism borders on pathologic, and is a defense against reality.8 Additionally, his reluctance to accept that he is suffering from depression, which he perceives as a weakness, will be a struggle throughout therapy. He likely will continue to minimize his symptoms when possible, making the true depths of his illness difficult to grasp.
Related Resources
- Waska R. Using countertransference: analytic contact, projective identification, and transference phantasy states. Am J Psychother. 2008;62(4):333-351.
- Gabbard GO, Litowitz BE, Williams P. Textbook of psychoanalysis. Arlington, VA: American Psychiatric Publishing, Inc; 2011.
Drug Brand Names
- Citalopram • Celexa
- Clonazepam • Klonopin
Disclosure
The authors report no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.
1. Blos P. Son and father: before and beyond the Oedipus complex. New York NY: Free Press/Macmillan; 1985.
2. Ursano RJ, Sonnenberg SM, Lazar SG. Concise guide to psychodynamic psychotherapy. Arlington VA: American Psychiatric Publishing; 2004.
3. Akhtar S. Comprehensive dictionary of psychoanalysis. London United Kingdom: Kamac Books; 2009.
4. Busch FN, Milrod BL, Singer MB. Theory and technique in psychodynamic treatment of panic disorder. J Psychother Pract Res. 1999;8(3):234-242.
5. Freud S. The future prospects of psycho-analytic therapy. The standard edition of the complete psychological works of Sigmund Freud volume XI (1910): five lectures on psycho-analysis, Leonardo da Vinci and other works. London, United Kingdom: Hogarth Press; 1957:139–152.
6. Winnicott DW. Hate in the counter-transference. J Psychother Pract Res. 1994;3(4):348-356.
7. Maltsberger JT, Buie DH. Countertransference hate in the treatment of suicidal patients. Arch Gen Psychiatry. 1974;30(5):625-633.
8. Akhtar S. “Someday…” and “if only…” fantasies: pathological optimism and inordinate nostalgia as related forms of idealization. J Am Psychoanal Assoc. 1996;44(3):723-753.
1. Blos P. Son and father: before and beyond the Oedipus complex. New York NY: Free Press/Macmillan; 1985.
2. Ursano RJ, Sonnenberg SM, Lazar SG. Concise guide to psychodynamic psychotherapy. Arlington VA: American Psychiatric Publishing; 2004.
3. Akhtar S. Comprehensive dictionary of psychoanalysis. London United Kingdom: Kamac Books; 2009.
4. Busch FN, Milrod BL, Singer MB. Theory and technique in psychodynamic treatment of panic disorder. J Psychother Pract Res. 1999;8(3):234-242.
5. Freud S. The future prospects of psycho-analytic therapy. The standard edition of the complete psychological works of Sigmund Freud volume XI (1910): five lectures on psycho-analysis, Leonardo da Vinci and other works. London, United Kingdom: Hogarth Press; 1957:139–152.
6. Winnicott DW. Hate in the counter-transference. J Psychother Pract Res. 1994;3(4):348-356.
7. Maltsberger JT, Buie DH. Countertransference hate in the treatment of suicidal patients. Arch Gen Psychiatry. 1974;30(5):625-633.
8. Akhtar S. “Someday…” and “if only…” fantasies: pathological optimism and inordinate nostalgia as related forms of idealization. J Am Psychoanal Assoc. 1996;44(3):723-753.
Prolonged delivery: child with CP awarded $70M … and more
AFTER MORE THAN 4 HOURS of second-stage labor followed by prolonged pushing and crowning, the baby was born depressed. Later, the child was found to have cerebral palsy.
PARENTS’ CLAIM The ObGyn was negligent in failing to perform an episiotomy, not attempting vacuum extraction, and not using forceps to assist delivery. Although fetal heart-rate monitoring results deteriorated, the ObGyn did not assess contractions for 30 minutes at one point. Hospital staff members were unable to adequately intubate or ventilate the newborn. The hospital staff disposed of the baby’s cord blood. Records were altered.
The parents’ counsel proposed that the defendants’ insurance company refused all settlement efforts prior to trial because the case venue was known to be conservative regarding jury verdicts.
DEFENDANTS’ DEFENSE The hospital and the ObGyn were not negligent; the mother and baby received proper care. Hospital staff acted appropriately.
VERDICT During the trial, the hospital settled for an undisclosed amount. An additional $2 million was offered on behalf of the ObGyn later in the trial, but the parents refused settlement at that time.
A California jury returned a $74.525 million verdict against the ObGyn. The child was awarded $70.725 million for medical expenses, lost earnings, and damages. The parents were awarded $3.8 million for emotional distress.
Was ectopic pregnancy missed?
A WOMAN IN SEVERE ABDOMINAL PAIN saw her internist. CT scans revealed a right ovarian cyst. When pain continued, she saw her ObGyn 3 weeks later, and her bowel was full of hard stool. Ultrasonography (US) showed a multicystic right ovary and a thin endometrial stripe. She was taking birth control pills and her husband had a vasectomy. She was told her abdominal pain was from constipation and ovarian cysts. A week later, she had laparoscopic surgery to remove an ectopic pregnancy.
PATIENT’S CLAIM The ObGyn did not perform a pregnancy test, and did not diagnose an ectopic pregnancy in a timely manner. An earlier diagnosis would have allowed medical rather than surgical resolution.
PHYSICIAN’S DEFENSE It was too early to determine if the pregnancy was intrauterine or ectopic. An earlier diagnosis would have resulted in laparoscopic surgery rather than medical treatment, as the medication (methotrexate) can cause increased pain.
VERDICT An Illinois defense verdict was returned.
Foreshortened vagina inhibits intercourse
A 65-YEAR-OLD WOMAN underwent anterior and posterior colphorrhaphy to repair a cystocele and rectocele, sacrospinous ligament fixation for vaginal prolapse, and a TVT mid-urethral suspension procedure to correct stress urinary incontinence. During two follow-up visits, the gynecologist determined that she was healing normally.
Within the next few weeks, the patient came to believe that her vagina had been sewn shut. She did not return to her gynecologist, but sought treatment with another physician 6 months later. It was determined that she had a stenotic and foreshortened vagina.
PATIENT’S CLAIM Too much vaginal tissue was removed during surgery.
PHYSICIAN’S DEFENSE The stenotic and foreshortened vagina was an unexpected result of the healing process after surgery.
VERDICT An Illinois defense verdict was returned.
Hydrocephalus in utero not seen until too late
A WOMAN HAD PRENATAL TREATMENT at a federally funded health clinic. A certified nurse midwife (CNM) ordered second-trimester US, with normal results. During the third trimester, the mother switched to a private ObGyn who ordered testing. US indicated the fetus was hydrocephalic. The child was born with cognitive disabilities and will need lifelong care.
PARENTS’ CLAIM The CNM ordered US too early in the pregnancy to be of diagnostic value; no further testing was undertaken. When hydrocephalus was seen, an abortion was not legally available because of fetal age.
DEFENDANT’S DEFENSE Even if US had been performed later in the second trimester, the defect would not have shown.
VERDICT A $4 million New Jersey settlement was reached.
WHEN SHOULDER DYSTOCIA WAS ENCOUNTERED, the ObGyn used standard maneuvers to deliver the child. The baby suffered a severe brachial plexus injury with rupture of C7 nerve and avulsions at C8 and T1.
Nerve-graft surgery at 6 months and tendon transfer surgery at 2 years resulted in recovery of good shoulder and elbow function, but the child has inadequate use of his wrist and hand. Additional surgeries are planned.
PARENTS’ CLAIM The ObGyn did not inform the mother that she was at risk for shoulder dystocia, nor did he discuss cesarean delivery. The mother’s risk factors included short stature, gestational diabetes, excessive weight gain during pregnancy, and two previous deliveries that involved vacuum assistance and a broken clavicle. The ObGyn applied excessive traction to the fetal head during delivery.
PHYSICIAN’S DEFENSE The mother’s risk factors were not severe enough to consider the chance of shoulder dystocia. The baby’s injuries were due to the normal forces of labor. Traction placed on the baby’s head during delivery was gentle and appropriate.
VERDICT A $5.5 million Iowa verdict was returned.
Faulty testing: baby has Down syndrome
AT 13 WEEKS’ GESTATION, a 34-year-old woman underwent chorionic villus sampling (CVS) at a maternal-fetal medicine center. Results showed a normal chromosomal profile. Later, two sonograms indicated possible Down syndrome. The parents were assured that the baby did not have a genetic disorder; amniocentesis was never suggested.
A week before the baby’s birth, the parents were told the child has Down syndrome.
PARENTS’ CLAIM Maternal tissue, not fetal tissue, had been removed and tested during CVS. The parents would have aborted the fetus had they known she had Down syndrome.
DEFENDANTS’ DEFENSE CVS was properly administered.
VERDICT A $3 million Missouri verdict was returned against the center where the testing was performed.
Why did the uterus seem to be growing?
A 52-YEAR-OLD WOMAN’S UTERUS was larger than normal in February 2007. By November 2008, her uterus was the size of a 14-week gestation. In September 2009, she complained of abdominal discomfort. Her uterus was larger than at the previous visit. The gynecologist suggested a hysterectomy, but nothing was scheduled.
In November 2009, she reported increasing pelvic pressure; her uterus was the size of an 18-week gestation. US and MRI showed large masses on both ovaries although the uterus had no masses or fibroids within it. A gynecologic oncologist performed abdominal hysterectomy with bilateral salpingo-oophorectomy and bilateral peri-aortic lymph node dissection. Pathology returned a diagnosis of ovarian cancer. The patient underwent chemotherapy.
PATIENT’S CLAIM The gynecologist was negligent in not ordering testing in 2007 when the larger-than-normal uterus was first detected, or in subsequent visits through September 2009. A more timely reaction would have given her an opportunity to treat the cancer at an earlier stage.
PHYSICIAN’S DEFENSE The case was settled before trial.
VERDICT A $650,000 Maryland settlement was reached.
Erb’s palsy after shoulder dystocia
DURING VAGINAL DELIVERY, the ObGyn encountered shoulder dystocia. The child suffered a brachial plexus injury and has Erb’s palsy. There was some improvement after two operations, but she still has muscle weakness, arm-length discrepancy, and limited range of motion.
PARENTS’ CLAIM The ObGyn applied excessive downward traction on the baby’s head when her left shoulder could not pass under the pubic bone.
PHYSICIAN’S DEFENSE The injury was caused by uterine contractions and maternal pushing. Proper maneuvers and gentle pressure were used.
VERDICT A $1.34 million New Jersey verdict was returned.
These cases were selected by the editors of OBG Management from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska (www.verdictslaska.com). The information available to the editors about the cases presented here is sometimes incomplete. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.
We want to hear from you! Tell us what you think.
AFTER MORE THAN 4 HOURS of second-stage labor followed by prolonged pushing and crowning, the baby was born depressed. Later, the child was found to have cerebral palsy.
PARENTS’ CLAIM The ObGyn was negligent in failing to perform an episiotomy, not attempting vacuum extraction, and not using forceps to assist delivery. Although fetal heart-rate monitoring results deteriorated, the ObGyn did not assess contractions for 30 minutes at one point. Hospital staff members were unable to adequately intubate or ventilate the newborn. The hospital staff disposed of the baby’s cord blood. Records were altered.
The parents’ counsel proposed that the defendants’ insurance company refused all settlement efforts prior to trial because the case venue was known to be conservative regarding jury verdicts.
DEFENDANTS’ DEFENSE The hospital and the ObGyn were not negligent; the mother and baby received proper care. Hospital staff acted appropriately.
VERDICT During the trial, the hospital settled for an undisclosed amount. An additional $2 million was offered on behalf of the ObGyn later in the trial, but the parents refused settlement at that time.
A California jury returned a $74.525 million verdict against the ObGyn. The child was awarded $70.725 million for medical expenses, lost earnings, and damages. The parents were awarded $3.8 million for emotional distress.
Was ectopic pregnancy missed?
A WOMAN IN SEVERE ABDOMINAL PAIN saw her internist. CT scans revealed a right ovarian cyst. When pain continued, she saw her ObGyn 3 weeks later, and her bowel was full of hard stool. Ultrasonography (US) showed a multicystic right ovary and a thin endometrial stripe. She was taking birth control pills and her husband had a vasectomy. She was told her abdominal pain was from constipation and ovarian cysts. A week later, she had laparoscopic surgery to remove an ectopic pregnancy.
PATIENT’S CLAIM The ObGyn did not perform a pregnancy test, and did not diagnose an ectopic pregnancy in a timely manner. An earlier diagnosis would have allowed medical rather than surgical resolution.
PHYSICIAN’S DEFENSE It was too early to determine if the pregnancy was intrauterine or ectopic. An earlier diagnosis would have resulted in laparoscopic surgery rather than medical treatment, as the medication (methotrexate) can cause increased pain.
VERDICT An Illinois defense verdict was returned.
Foreshortened vagina inhibits intercourse
A 65-YEAR-OLD WOMAN underwent anterior and posterior colphorrhaphy to repair a cystocele and rectocele, sacrospinous ligament fixation for vaginal prolapse, and a TVT mid-urethral suspension procedure to correct stress urinary incontinence. During two follow-up visits, the gynecologist determined that she was healing normally.
Within the next few weeks, the patient came to believe that her vagina had been sewn shut. She did not return to her gynecologist, but sought treatment with another physician 6 months later. It was determined that she had a stenotic and foreshortened vagina.
PATIENT’S CLAIM Too much vaginal tissue was removed during surgery.
PHYSICIAN’S DEFENSE The stenotic and foreshortened vagina was an unexpected result of the healing process after surgery.
VERDICT An Illinois defense verdict was returned.
Hydrocephalus in utero not seen until too late
A WOMAN HAD PRENATAL TREATMENT at a federally funded health clinic. A certified nurse midwife (CNM) ordered second-trimester US, with normal results. During the third trimester, the mother switched to a private ObGyn who ordered testing. US indicated the fetus was hydrocephalic. The child was born with cognitive disabilities and will need lifelong care.
PARENTS’ CLAIM The CNM ordered US too early in the pregnancy to be of diagnostic value; no further testing was undertaken. When hydrocephalus was seen, an abortion was not legally available because of fetal age.
DEFENDANT’S DEFENSE Even if US had been performed later in the second trimester, the defect would not have shown.
VERDICT A $4 million New Jersey settlement was reached.
WHEN SHOULDER DYSTOCIA WAS ENCOUNTERED, the ObGyn used standard maneuvers to deliver the child. The baby suffered a severe brachial plexus injury with rupture of C7 nerve and avulsions at C8 and T1.
Nerve-graft surgery at 6 months and tendon transfer surgery at 2 years resulted in recovery of good shoulder and elbow function, but the child has inadequate use of his wrist and hand. Additional surgeries are planned.
PARENTS’ CLAIM The ObGyn did not inform the mother that she was at risk for shoulder dystocia, nor did he discuss cesarean delivery. The mother’s risk factors included short stature, gestational diabetes, excessive weight gain during pregnancy, and two previous deliveries that involved vacuum assistance and a broken clavicle. The ObGyn applied excessive traction to the fetal head during delivery.
PHYSICIAN’S DEFENSE The mother’s risk factors were not severe enough to consider the chance of shoulder dystocia. The baby’s injuries were due to the normal forces of labor. Traction placed on the baby’s head during delivery was gentle and appropriate.
VERDICT A $5.5 million Iowa verdict was returned.
Faulty testing: baby has Down syndrome
AT 13 WEEKS’ GESTATION, a 34-year-old woman underwent chorionic villus sampling (CVS) at a maternal-fetal medicine center. Results showed a normal chromosomal profile. Later, two sonograms indicated possible Down syndrome. The parents were assured that the baby did not have a genetic disorder; amniocentesis was never suggested.
A week before the baby’s birth, the parents were told the child has Down syndrome.
PARENTS’ CLAIM Maternal tissue, not fetal tissue, had been removed and tested during CVS. The parents would have aborted the fetus had they known she had Down syndrome.
DEFENDANTS’ DEFENSE CVS was properly administered.
VERDICT A $3 million Missouri verdict was returned against the center where the testing was performed.
Why did the uterus seem to be growing?
A 52-YEAR-OLD WOMAN’S UTERUS was larger than normal in February 2007. By November 2008, her uterus was the size of a 14-week gestation. In September 2009, she complained of abdominal discomfort. Her uterus was larger than at the previous visit. The gynecologist suggested a hysterectomy, but nothing was scheduled.
In November 2009, she reported increasing pelvic pressure; her uterus was the size of an 18-week gestation. US and MRI showed large masses on both ovaries although the uterus had no masses or fibroids within it. A gynecologic oncologist performed abdominal hysterectomy with bilateral salpingo-oophorectomy and bilateral peri-aortic lymph node dissection. Pathology returned a diagnosis of ovarian cancer. The patient underwent chemotherapy.
PATIENT’S CLAIM The gynecologist was negligent in not ordering testing in 2007 when the larger-than-normal uterus was first detected, or in subsequent visits through September 2009. A more timely reaction would have given her an opportunity to treat the cancer at an earlier stage.
PHYSICIAN’S DEFENSE The case was settled before trial.
VERDICT A $650,000 Maryland settlement was reached.
Erb’s palsy after shoulder dystocia
DURING VAGINAL DELIVERY, the ObGyn encountered shoulder dystocia. The child suffered a brachial plexus injury and has Erb’s palsy. There was some improvement after two operations, but she still has muscle weakness, arm-length discrepancy, and limited range of motion.
PARENTS’ CLAIM The ObGyn applied excessive downward traction on the baby’s head when her left shoulder could not pass under the pubic bone.
PHYSICIAN’S DEFENSE The injury was caused by uterine contractions and maternal pushing. Proper maneuvers and gentle pressure were used.
VERDICT A $1.34 million New Jersey verdict was returned.
AFTER MORE THAN 4 HOURS of second-stage labor followed by prolonged pushing and crowning, the baby was born depressed. Later, the child was found to have cerebral palsy.
PARENTS’ CLAIM The ObGyn was negligent in failing to perform an episiotomy, not attempting vacuum extraction, and not using forceps to assist delivery. Although fetal heart-rate monitoring results deteriorated, the ObGyn did not assess contractions for 30 minutes at one point. Hospital staff members were unable to adequately intubate or ventilate the newborn. The hospital staff disposed of the baby’s cord blood. Records were altered.
The parents’ counsel proposed that the defendants’ insurance company refused all settlement efforts prior to trial because the case venue was known to be conservative regarding jury verdicts.
DEFENDANTS’ DEFENSE The hospital and the ObGyn were not negligent; the mother and baby received proper care. Hospital staff acted appropriately.
VERDICT During the trial, the hospital settled for an undisclosed amount. An additional $2 million was offered on behalf of the ObGyn later in the trial, but the parents refused settlement at that time.
A California jury returned a $74.525 million verdict against the ObGyn. The child was awarded $70.725 million for medical expenses, lost earnings, and damages. The parents were awarded $3.8 million for emotional distress.
Was ectopic pregnancy missed?
A WOMAN IN SEVERE ABDOMINAL PAIN saw her internist. CT scans revealed a right ovarian cyst. When pain continued, she saw her ObGyn 3 weeks later, and her bowel was full of hard stool. Ultrasonography (US) showed a multicystic right ovary and a thin endometrial stripe. She was taking birth control pills and her husband had a vasectomy. She was told her abdominal pain was from constipation and ovarian cysts. A week later, she had laparoscopic surgery to remove an ectopic pregnancy.
PATIENT’S CLAIM The ObGyn did not perform a pregnancy test, and did not diagnose an ectopic pregnancy in a timely manner. An earlier diagnosis would have allowed medical rather than surgical resolution.
PHYSICIAN’S DEFENSE It was too early to determine if the pregnancy was intrauterine or ectopic. An earlier diagnosis would have resulted in laparoscopic surgery rather than medical treatment, as the medication (methotrexate) can cause increased pain.
VERDICT An Illinois defense verdict was returned.
Foreshortened vagina inhibits intercourse
A 65-YEAR-OLD WOMAN underwent anterior and posterior colphorrhaphy to repair a cystocele and rectocele, sacrospinous ligament fixation for vaginal prolapse, and a TVT mid-urethral suspension procedure to correct stress urinary incontinence. During two follow-up visits, the gynecologist determined that she was healing normally.
Within the next few weeks, the patient came to believe that her vagina had been sewn shut. She did not return to her gynecologist, but sought treatment with another physician 6 months later. It was determined that she had a stenotic and foreshortened vagina.
PATIENT’S CLAIM Too much vaginal tissue was removed during surgery.
PHYSICIAN’S DEFENSE The stenotic and foreshortened vagina was an unexpected result of the healing process after surgery.
VERDICT An Illinois defense verdict was returned.
Hydrocephalus in utero not seen until too late
A WOMAN HAD PRENATAL TREATMENT at a federally funded health clinic. A certified nurse midwife (CNM) ordered second-trimester US, with normal results. During the third trimester, the mother switched to a private ObGyn who ordered testing. US indicated the fetus was hydrocephalic. The child was born with cognitive disabilities and will need lifelong care.
PARENTS’ CLAIM The CNM ordered US too early in the pregnancy to be of diagnostic value; no further testing was undertaken. When hydrocephalus was seen, an abortion was not legally available because of fetal age.
DEFENDANT’S DEFENSE Even if US had been performed later in the second trimester, the defect would not have shown.
VERDICT A $4 million New Jersey settlement was reached.
WHEN SHOULDER DYSTOCIA WAS ENCOUNTERED, the ObGyn used standard maneuvers to deliver the child. The baby suffered a severe brachial plexus injury with rupture of C7 nerve and avulsions at C8 and T1.
Nerve-graft surgery at 6 months and tendon transfer surgery at 2 years resulted in recovery of good shoulder and elbow function, but the child has inadequate use of his wrist and hand. Additional surgeries are planned.
PARENTS’ CLAIM The ObGyn did not inform the mother that she was at risk for shoulder dystocia, nor did he discuss cesarean delivery. The mother’s risk factors included short stature, gestational diabetes, excessive weight gain during pregnancy, and two previous deliveries that involved vacuum assistance and a broken clavicle. The ObGyn applied excessive traction to the fetal head during delivery.
PHYSICIAN’S DEFENSE The mother’s risk factors were not severe enough to consider the chance of shoulder dystocia. The baby’s injuries were due to the normal forces of labor. Traction placed on the baby’s head during delivery was gentle and appropriate.
VERDICT A $5.5 million Iowa verdict was returned.
Faulty testing: baby has Down syndrome
AT 13 WEEKS’ GESTATION, a 34-year-old woman underwent chorionic villus sampling (CVS) at a maternal-fetal medicine center. Results showed a normal chromosomal profile. Later, two sonograms indicated possible Down syndrome. The parents were assured that the baby did not have a genetic disorder; amniocentesis was never suggested.
A week before the baby’s birth, the parents were told the child has Down syndrome.
PARENTS’ CLAIM Maternal tissue, not fetal tissue, had been removed and tested during CVS. The parents would have aborted the fetus had they known she had Down syndrome.
DEFENDANTS’ DEFENSE CVS was properly administered.
VERDICT A $3 million Missouri verdict was returned against the center where the testing was performed.
Why did the uterus seem to be growing?
A 52-YEAR-OLD WOMAN’S UTERUS was larger than normal in February 2007. By November 2008, her uterus was the size of a 14-week gestation. In September 2009, she complained of abdominal discomfort. Her uterus was larger than at the previous visit. The gynecologist suggested a hysterectomy, but nothing was scheduled.
In November 2009, she reported increasing pelvic pressure; her uterus was the size of an 18-week gestation. US and MRI showed large masses on both ovaries although the uterus had no masses or fibroids within it. A gynecologic oncologist performed abdominal hysterectomy with bilateral salpingo-oophorectomy and bilateral peri-aortic lymph node dissection. Pathology returned a diagnosis of ovarian cancer. The patient underwent chemotherapy.
PATIENT’S CLAIM The gynecologist was negligent in not ordering testing in 2007 when the larger-than-normal uterus was first detected, or in subsequent visits through September 2009. A more timely reaction would have given her an opportunity to treat the cancer at an earlier stage.
PHYSICIAN’S DEFENSE The case was settled before trial.
VERDICT A $650,000 Maryland settlement was reached.
Erb’s palsy after shoulder dystocia
DURING VAGINAL DELIVERY, the ObGyn encountered shoulder dystocia. The child suffered a brachial plexus injury and has Erb’s palsy. There was some improvement after two operations, but she still has muscle weakness, arm-length discrepancy, and limited range of motion.
PARENTS’ CLAIM The ObGyn applied excessive downward traction on the baby’s head when her left shoulder could not pass under the pubic bone.
PHYSICIAN’S DEFENSE The injury was caused by uterine contractions and maternal pushing. Proper maneuvers and gentle pressure were used.
VERDICT A $1.34 million New Jersey verdict was returned.
These cases were selected by the editors of OBG Management from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska (www.verdictslaska.com). The information available to the editors about the cases presented here is sometimes incomplete. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.
We want to hear from you! Tell us what you think.
These cases were selected by the editors of OBG Management from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska (www.verdictslaska.com). The information available to the editors about the cases presented here is sometimes incomplete. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.
We want to hear from you! Tell us what you think.
Does mediolateral episiotomy reduce the risk of anal sphincter injury in operative vaginal delivery?
Stop performing median episiotomy!
Robert L. Barbieri, MD (Editorial, April 2012)
Episiotomy is an incision into the perineal body that is made during the second stage of labor to expedite delivery. Despite guidelines recommending restrictions on its use, episiotomy is still performed in more than 25% of vaginal deliveries in the United States. Suggested benefits include a shortened second stage of labor, the substitution of a straight surgical incision for a ragged spontaneous tear, and a reduced incidence of severe perineal injury and resultant pelvic floor dysfunction. Few data support these assertions, however.
Episiotomy is no OASIS
Absolute indications for episiotomy have yet to be established. Although there is general agreement that episiotomy may be indicated in select circumstances (such as to expedite delivery in the setting of nonreassuring fetal testing in the second stage of labor, shoulder dystocia, or at the time of operative vaginal delivery), routine use is discouraged.1,2 Besides the lack of data showing its benefit, episiotomy is associated with several potential complications, including increased blood loss, fetal injury, and localized pain. In contrast to the stated goal of reducing perineal trauma, episiotomy is associated with an increased incidence of third- or fourth-degree perineal lacerations,3,4 referred to in this study as obstetric anal sphincter injuries (OASIS).
Third- or fourth-degree tears are identified clinically at the time of vaginal delivery in 0.6% to 9% of patients.4 Studies using two-dimensional endoanal ultrasonography suggest that the true incidence of rectal injury is probably closer to 11%.5 Such injuries are associated with an increased risk of subsequent urinary or fecal incontinence (or both) and pelvic organ prolapse.
If episiotomy is indicated, how should it be performed?
There are two main types of episiotomy: median (favored in the United States) and mediolateral episiotomy. Complications—especially OASIS—are more common with median episiotomy,3,6,7 which involves a vertical midline incision from the posterior fourchette toward the rectum. Mediolateral episiotomy (favored in Europe), refers to an incision performed at a 45° angle from the posterior fourchette. OASIS is more common after median episiotomy, compared with the mediolateral approach.4,6 What is not yet clear is whether mediolateral episiotomy actually protects against OASIS.
Details of the study
de Vogel and colleagues evaluated the frequency of OASIS in women at high risk—specifically, those undergoing operative vaginal delivery; they also sought to determine whether mediolateral episiotomy is protective against OASIS. To this end, they performed a retrospective analysis of 2,861 consecutive women who delivered a singleton liveborn infant at term by vacuum, forceps, or both, from 2001–2009. Women were identified through the Netherlands Perinatal Registry, a voluntary reporting national database that includes approximately 96% of the 190,000 births that occur after 16 weeks’ gestation each year in the Netherlands. Exclusion criteria included multiple gestation, breech presentation, and use of median episiotomy.
The overall frequency of OASIS was 5.7% (162 cases among 2,861 deliveries). After logistic-regression modeling, a number of variables were significantly associated with OASIS, all of which have been identified previously: forceps delivery, occiput posterior position, primiparity, and epidural anesthesia. Women with a mediolateral episiotomy were at a significantly lower risk for OASIS, compared with women without mediolateral episiotomy (3.5% vs 15.6%, respectively; P<.001). Further analysis suggested that 8.6 mediolateral episiotomies would be needed to prevent one OASIS during vacuum extraction, whereas 5.2 procedures would be necessary to prevent one OASIS during forceps delivery. de Vogel and colleagues concluded that mediolateral episiotomy should be performed during all operative vaginal deliveries to reduce the incidence of OASIS.
Although this study included a large sample from a well-established and validated dataset (collected prospectively), it was, by design, retrospective. There was no standardization of when or how to cut the mediolateral episiotomy. However, many of these uncontrolled variables (such as cutting an episiotomy that is more median than mediolateral or cutting an episiotomy only in women who appear to be at imminent risk of sustaining a perineal laceration) would increase—not decrease—the risk of severe perineal injury. This fact suggests that the protective effect of mediolateral episiotomy may be even more dramatic than the sixfold protection reported in this study.
This study focused on women who underwent operative vaginal delivery. It remains controversial whether mediolateral episiotomy is protective in women who have a spontaneous (noninstrumental) vaginal delivery.
The study also lacks follow-up data on how many women with OASIS went on to develop fecal or urinary incontinence or pelvic organ prolapse. However, a third- or fourth-degree perineal laceration is serious enough that it can serve as an acceptable primary outcome measure even in the absence of long-term functional data.
In this study, use of median episiotomy was an exclusion, mostly likely because it is rarely performed in Europe.
While the battle over “to cut or not to cut” continues to rage, one fact is clear: median episiotomy should be abandoned. If you are going to perform episiotomy, make it mediolateral. According to this report, accoucheurs should consider cutting a mediolateral episiotomy for perineal protection each time they perform operative vaginal delivery.
ERROL R. NORWITZ, MD, PHD
After reading this article, and Dr. Barbieri’s April Editorial, we want to know if these articles have changed your practice. If you were faced with a difficult vaginal delivery, would you use a median or mediolateral episiotomy incision? Why?
We want to hear from you! Tell us what you think.
1. Hartmann K, Viswanathan M, Palmieri R, Gartlehner G, Thorp J, Lohr KN. Outcomes of routine episiotomy: a systematic review. JAMA. 2005;293(17):2141-2148.
2. Carroli G, Mignini L. Episiotomy for vaginal birth. Cochrane Database Syst Rev. 2009;(1):CD000081.-
3. Helwig JT, Thorp JM, Jr, Bowes WA, Jr. Does midline episiotomy increase the risk of third- and fourth-degree lacerations in operative vaginal deliveries? Obstet Gynecol. 1993;82(2):276-279.
4. Dudding TC, Vaizey C, Kamm MA. Obstetric anal sphincter injury: incidence, risk factors, and management. Ann Surg. 2008;247(2):224-237.
5. Williams AB, Bartram CI, Halligan S, Spencer JA, Nicholls RJ, Kmiot WA. Anal sphincter damage after vaginal delivery using three-dimensional endosonography. Obstet Gynecol. 2001;97(5 Pt 1):770-775.
6. Coats PM, Chan KK, Wilkins M, Beard RJ. A comparison between midline and mediolateral episiotomies. Br J Obstet Gynaecol. 1980;87(5):408-412.
7. Kudish B, Blackwell S, McNeeley SG, et al. Operative vaginal delivery and midline episiotomy: a bad combination for the perineum. Am J Obstet Gynecol. 2006;195(3):749-754.
Stop performing median episiotomy!
Robert L. Barbieri, MD (Editorial, April 2012)
Episiotomy is an incision into the perineal body that is made during the second stage of labor to expedite delivery. Despite guidelines recommending restrictions on its use, episiotomy is still performed in more than 25% of vaginal deliveries in the United States. Suggested benefits include a shortened second stage of labor, the substitution of a straight surgical incision for a ragged spontaneous tear, and a reduced incidence of severe perineal injury and resultant pelvic floor dysfunction. Few data support these assertions, however.
Episiotomy is no OASIS
Absolute indications for episiotomy have yet to be established. Although there is general agreement that episiotomy may be indicated in select circumstances (such as to expedite delivery in the setting of nonreassuring fetal testing in the second stage of labor, shoulder dystocia, or at the time of operative vaginal delivery), routine use is discouraged.1,2 Besides the lack of data showing its benefit, episiotomy is associated with several potential complications, including increased blood loss, fetal injury, and localized pain. In contrast to the stated goal of reducing perineal trauma, episiotomy is associated with an increased incidence of third- or fourth-degree perineal lacerations,3,4 referred to in this study as obstetric anal sphincter injuries (OASIS).
Third- or fourth-degree tears are identified clinically at the time of vaginal delivery in 0.6% to 9% of patients.4 Studies using two-dimensional endoanal ultrasonography suggest that the true incidence of rectal injury is probably closer to 11%.5 Such injuries are associated with an increased risk of subsequent urinary or fecal incontinence (or both) and pelvic organ prolapse.
If episiotomy is indicated, how should it be performed?
There are two main types of episiotomy: median (favored in the United States) and mediolateral episiotomy. Complications—especially OASIS—are more common with median episiotomy,3,6,7 which involves a vertical midline incision from the posterior fourchette toward the rectum. Mediolateral episiotomy (favored in Europe), refers to an incision performed at a 45° angle from the posterior fourchette. OASIS is more common after median episiotomy, compared with the mediolateral approach.4,6 What is not yet clear is whether mediolateral episiotomy actually protects against OASIS.
Details of the study
de Vogel and colleagues evaluated the frequency of OASIS in women at high risk—specifically, those undergoing operative vaginal delivery; they also sought to determine whether mediolateral episiotomy is protective against OASIS. To this end, they performed a retrospective analysis of 2,861 consecutive women who delivered a singleton liveborn infant at term by vacuum, forceps, or both, from 2001–2009. Women were identified through the Netherlands Perinatal Registry, a voluntary reporting national database that includes approximately 96% of the 190,000 births that occur after 16 weeks’ gestation each year in the Netherlands. Exclusion criteria included multiple gestation, breech presentation, and use of median episiotomy.
The overall frequency of OASIS was 5.7% (162 cases among 2,861 deliveries). After logistic-regression modeling, a number of variables were significantly associated with OASIS, all of which have been identified previously: forceps delivery, occiput posterior position, primiparity, and epidural anesthesia. Women with a mediolateral episiotomy were at a significantly lower risk for OASIS, compared with women without mediolateral episiotomy (3.5% vs 15.6%, respectively; P<.001). Further analysis suggested that 8.6 mediolateral episiotomies would be needed to prevent one OASIS during vacuum extraction, whereas 5.2 procedures would be necessary to prevent one OASIS during forceps delivery. de Vogel and colleagues concluded that mediolateral episiotomy should be performed during all operative vaginal deliveries to reduce the incidence of OASIS.
Although this study included a large sample from a well-established and validated dataset (collected prospectively), it was, by design, retrospective. There was no standardization of when or how to cut the mediolateral episiotomy. However, many of these uncontrolled variables (such as cutting an episiotomy that is more median than mediolateral or cutting an episiotomy only in women who appear to be at imminent risk of sustaining a perineal laceration) would increase—not decrease—the risk of severe perineal injury. This fact suggests that the protective effect of mediolateral episiotomy may be even more dramatic than the sixfold protection reported in this study.
This study focused on women who underwent operative vaginal delivery. It remains controversial whether mediolateral episiotomy is protective in women who have a spontaneous (noninstrumental) vaginal delivery.
The study also lacks follow-up data on how many women with OASIS went on to develop fecal or urinary incontinence or pelvic organ prolapse. However, a third- or fourth-degree perineal laceration is serious enough that it can serve as an acceptable primary outcome measure even in the absence of long-term functional data.
In this study, use of median episiotomy was an exclusion, mostly likely because it is rarely performed in Europe.
While the battle over “to cut or not to cut” continues to rage, one fact is clear: median episiotomy should be abandoned. If you are going to perform episiotomy, make it mediolateral. According to this report, accoucheurs should consider cutting a mediolateral episiotomy for perineal protection each time they perform operative vaginal delivery.
ERROL R. NORWITZ, MD, PHD
After reading this article, and Dr. Barbieri’s April Editorial, we want to know if these articles have changed your practice. If you were faced with a difficult vaginal delivery, would you use a median or mediolateral episiotomy incision? Why?
We want to hear from you! Tell us what you think.
Stop performing median episiotomy!
Robert L. Barbieri, MD (Editorial, April 2012)
Episiotomy is an incision into the perineal body that is made during the second stage of labor to expedite delivery. Despite guidelines recommending restrictions on its use, episiotomy is still performed in more than 25% of vaginal deliveries in the United States. Suggested benefits include a shortened second stage of labor, the substitution of a straight surgical incision for a ragged spontaneous tear, and a reduced incidence of severe perineal injury and resultant pelvic floor dysfunction. Few data support these assertions, however.
Episiotomy is no OASIS
Absolute indications for episiotomy have yet to be established. Although there is general agreement that episiotomy may be indicated in select circumstances (such as to expedite delivery in the setting of nonreassuring fetal testing in the second stage of labor, shoulder dystocia, or at the time of operative vaginal delivery), routine use is discouraged.1,2 Besides the lack of data showing its benefit, episiotomy is associated with several potential complications, including increased blood loss, fetal injury, and localized pain. In contrast to the stated goal of reducing perineal trauma, episiotomy is associated with an increased incidence of third- or fourth-degree perineal lacerations,3,4 referred to in this study as obstetric anal sphincter injuries (OASIS).
Third- or fourth-degree tears are identified clinically at the time of vaginal delivery in 0.6% to 9% of patients.4 Studies using two-dimensional endoanal ultrasonography suggest that the true incidence of rectal injury is probably closer to 11%.5 Such injuries are associated with an increased risk of subsequent urinary or fecal incontinence (or both) and pelvic organ prolapse.
If episiotomy is indicated, how should it be performed?
There are two main types of episiotomy: median (favored in the United States) and mediolateral episiotomy. Complications—especially OASIS—are more common with median episiotomy,3,6,7 which involves a vertical midline incision from the posterior fourchette toward the rectum. Mediolateral episiotomy (favored in Europe), refers to an incision performed at a 45° angle from the posterior fourchette. OASIS is more common after median episiotomy, compared with the mediolateral approach.4,6 What is not yet clear is whether mediolateral episiotomy actually protects against OASIS.
Details of the study
de Vogel and colleagues evaluated the frequency of OASIS in women at high risk—specifically, those undergoing operative vaginal delivery; they also sought to determine whether mediolateral episiotomy is protective against OASIS. To this end, they performed a retrospective analysis of 2,861 consecutive women who delivered a singleton liveborn infant at term by vacuum, forceps, or both, from 2001–2009. Women were identified through the Netherlands Perinatal Registry, a voluntary reporting national database that includes approximately 96% of the 190,000 births that occur after 16 weeks’ gestation each year in the Netherlands. Exclusion criteria included multiple gestation, breech presentation, and use of median episiotomy.
The overall frequency of OASIS was 5.7% (162 cases among 2,861 deliveries). After logistic-regression modeling, a number of variables were significantly associated with OASIS, all of which have been identified previously: forceps delivery, occiput posterior position, primiparity, and epidural anesthesia. Women with a mediolateral episiotomy were at a significantly lower risk for OASIS, compared with women without mediolateral episiotomy (3.5% vs 15.6%, respectively; P<.001). Further analysis suggested that 8.6 mediolateral episiotomies would be needed to prevent one OASIS during vacuum extraction, whereas 5.2 procedures would be necessary to prevent one OASIS during forceps delivery. de Vogel and colleagues concluded that mediolateral episiotomy should be performed during all operative vaginal deliveries to reduce the incidence of OASIS.
Although this study included a large sample from a well-established and validated dataset (collected prospectively), it was, by design, retrospective. There was no standardization of when or how to cut the mediolateral episiotomy. However, many of these uncontrolled variables (such as cutting an episiotomy that is more median than mediolateral or cutting an episiotomy only in women who appear to be at imminent risk of sustaining a perineal laceration) would increase—not decrease—the risk of severe perineal injury. This fact suggests that the protective effect of mediolateral episiotomy may be even more dramatic than the sixfold protection reported in this study.
This study focused on women who underwent operative vaginal delivery. It remains controversial whether mediolateral episiotomy is protective in women who have a spontaneous (noninstrumental) vaginal delivery.
The study also lacks follow-up data on how many women with OASIS went on to develop fecal or urinary incontinence or pelvic organ prolapse. However, a third- or fourth-degree perineal laceration is serious enough that it can serve as an acceptable primary outcome measure even in the absence of long-term functional data.
In this study, use of median episiotomy was an exclusion, mostly likely because it is rarely performed in Europe.
While the battle over “to cut or not to cut” continues to rage, one fact is clear: median episiotomy should be abandoned. If you are going to perform episiotomy, make it mediolateral. According to this report, accoucheurs should consider cutting a mediolateral episiotomy for perineal protection each time they perform operative vaginal delivery.
ERROL R. NORWITZ, MD, PHD
After reading this article, and Dr. Barbieri’s April Editorial, we want to know if these articles have changed your practice. If you were faced with a difficult vaginal delivery, would you use a median or mediolateral episiotomy incision? Why?
We want to hear from you! Tell us what you think.
1. Hartmann K, Viswanathan M, Palmieri R, Gartlehner G, Thorp J, Lohr KN. Outcomes of routine episiotomy: a systematic review. JAMA. 2005;293(17):2141-2148.
2. Carroli G, Mignini L. Episiotomy for vaginal birth. Cochrane Database Syst Rev. 2009;(1):CD000081.-
3. Helwig JT, Thorp JM, Jr, Bowes WA, Jr. Does midline episiotomy increase the risk of third- and fourth-degree lacerations in operative vaginal deliveries? Obstet Gynecol. 1993;82(2):276-279.
4. Dudding TC, Vaizey C, Kamm MA. Obstetric anal sphincter injury: incidence, risk factors, and management. Ann Surg. 2008;247(2):224-237.
5. Williams AB, Bartram CI, Halligan S, Spencer JA, Nicholls RJ, Kmiot WA. Anal sphincter damage after vaginal delivery using three-dimensional endosonography. Obstet Gynecol. 2001;97(5 Pt 1):770-775.
6. Coats PM, Chan KK, Wilkins M, Beard RJ. A comparison between midline and mediolateral episiotomies. Br J Obstet Gynaecol. 1980;87(5):408-412.
7. Kudish B, Blackwell S, McNeeley SG, et al. Operative vaginal delivery and midline episiotomy: a bad combination for the perineum. Am J Obstet Gynecol. 2006;195(3):749-754.
1. Hartmann K, Viswanathan M, Palmieri R, Gartlehner G, Thorp J, Lohr KN. Outcomes of routine episiotomy: a systematic review. JAMA. 2005;293(17):2141-2148.
2. Carroli G, Mignini L. Episiotomy for vaginal birth. Cochrane Database Syst Rev. 2009;(1):CD000081.-
3. Helwig JT, Thorp JM, Jr, Bowes WA, Jr. Does midline episiotomy increase the risk of third- and fourth-degree lacerations in operative vaginal deliveries? Obstet Gynecol. 1993;82(2):276-279.
4. Dudding TC, Vaizey C, Kamm MA. Obstetric anal sphincter injury: incidence, risk factors, and management. Ann Surg. 2008;247(2):224-237.
5. Williams AB, Bartram CI, Halligan S, Spencer JA, Nicholls RJ, Kmiot WA. Anal sphincter damage after vaginal delivery using three-dimensional endosonography. Obstet Gynecol. 2001;97(5 Pt 1):770-775.
6. Coats PM, Chan KK, Wilkins M, Beard RJ. A comparison between midline and mediolateral episiotomies. Br J Obstet Gynaecol. 1980;87(5):408-412.
7. Kudish B, Blackwell S, McNeeley SG, et al. Operative vaginal delivery and midline episiotomy: a bad combination for the perineum. Am J Obstet Gynecol. 2006;195(3):749-754.
How to avoid major vessel injury during gynecologic laparoscopy
Update: Minimally invasive Surgery
Amy Garcia, MD (April 2012)
10 practical, evidence-based suggestions to improve your minimally invasive surgical skills now
Catherine A. Matthews, MD (April 2011)
CASE: Abdominal entry leads to life-threatening injury
A 50-year-old woman with a BMI of 25 kg/m2, a strong family history of breast and ovarian cancer, and a confirmed BRCA mutation was scheduled for prophylactic bilateral salpingo-oophorectomy via robotic laparoscopy on November 26, 2009. At the time of the procedure, the gynecologic surgeon selected a site for the camera trocar that was several centimeters above the umbilicus. After making a transverse incision, he inserted a Veress needle and insufflated the abdomen with CO2 gas until intra-abdominal pressure reached 17 mm Hg. He then thrust an 11-inch disposable trocar through the anterior abdominal wall, attached the camera to the laparoscope, confirmed proper intraperitoneal placement, and inserted two additional trocars under direct vision.
Shortly after these actions, the anesthesiologist reported that the patient’s blood pressure had dropped precipitously, along with end tidal CO2. The surgeon examined the peritoneal cavity and discovered blood in the right paracolic gutter. The anesthesiologist advised the surgeon that he could no longer detect the patient’s blood pressure; electrocardiography revealed pulseless electrical activity.
The surgical team began chest compressions, evacuated the pneumoperitoneum, and removed all trocars. Blood was noted on the camera trocar, and the device was secured by the OR staff. The surgeon performed an emergent laparotomy, making the incision within 4 minutes of the beginning of CPR. Exploration revealed a large retroperitoneal hematoma above the area of the aortic bifurcation and inferior vena cava.
General and vascular surgeons were called. The general surgeon opened the retroperitoneum and found an extreme amount of clotted and unclotted blood. The vascular surgeon described the initial injury as a 1.5-cm laceration of the distal aorta, just above the bifurcation. A cell saver was requested and recorded blood loss of 12,000 mL.
The vascular surgeon clamped the aorta proximally; he also clamped both common iliac arteries. He then repaired the lacerations on the aorta using 5-0 Prolene suture (Ethicon). The aorta was significantly narrowed, however, so the surgeon decided to replace the distal aorta, which he then resected and repaired using a 14-mm Dacron graft (DuPont).
Further inspection revealed continuing retroperitoneal bleeding. The vascular surgeon found and repaired a laceration of the inferior mesenteric vein. He also clipped multiple small veins to stop bleeding.
When a hole in the transverse colon was identified, the general surgeon—who had left the operating table—rescrubbed to repair it. He also discovered an injury to the mesentery of the transverse colon and repaired both wounds, resecting the perforated segment. The divided, stapled colon was dropped back into the abdomen because the bowel was dusky. Despite an epinephrine drip, the patient was hypotensive and coagulopathic. The abdomen was packed and covered with sterile cassette film, with towels covering the open wound.
The patient was taken to the postanesthesia care unit in guarded condition and was subsequently transferred to the ICU, where her blood pressure dropped again. She was returned to the OR, where the packs were removed and a bleeding right common iliac artery was repaired using 5-0 Prolene suture. The next day, she underwent bilateral salpingo-oophorectomy with a transverse colon colostomy.
Because of the colon injury, the vascular surgeon believed that the Dacron graft had been contaminated. On December 1, the graft was taken down, a left femoral-vein autograft was harvested, and a reconstructive conduit was created for the terminal aorta. The patient underwent three additional procedures to place mesh into the abdominal wall. When the mesh became infected, it was removed.
The patient remained in the hospital for 1 month, after which she was transferred to a long-term care facility. She suffered permanent neurologic injuries because of prolonged hypoxia and continues to require supportive care.
How could this catastrophe have been avoided?
Traumatic injury to the great retroperitoneal vessels is an emergent and life-threatening event. During gynecologic laparoscopy, it is most likely to occur during entry into the anterior abdominal wall.
Most laparoscopic procedures require entry into the anterior abdominal wall for placement of a trocar and a sleeve that serves as a portal for insertion of the endoscope. Secondary ports provide entry points for manipulative and operative tools.
The most critical entry point is primary placement of the viewing device. Secondary trocars are always inserted under direct visualization; therefore, they carry a lower risk of inflicting injury to underlying viscera and vessels.
Practice safe entry
In the early days of laparoscopy, only one method of entry existed. Over time, however, several other techniques have been devised.
The initial method—still widely utilized—is known as the closed or blind technique. The surgeon creates a pneumoperitoneum with the use of a needle that is 18 gauge to 2.5 mm in diameter; the needle is placed through a subumbilical incision. Once intraperitoneal placement is confirmed, CO2 gas is infused into the peritoneal cavity until the abdomen is tympanic to percussion (usually at pressures of 14 to 18 mm Hg).
Next, the surgeon aims the trocar toward the uterus at a 45° angle, maintaining the device in the midline. Entry is confirmed by opening the trocar’s trap-door valve and witnessing a rush of CO2 gas.
Another entry technique—the open technique—is used almost universally by general surgeons. The procedure is a type of microlaparotomy. After making the subumbilical incision, the fascia of the abdominal wall is pierced and the peritoneum is grasped and opened bluntly or sharply. Once the edges of the peritoneum are secured, a blunt trocar (Hasson trocar) is inserted. Then the trocar is removed, leaving the sleeve in place to accept the laparoscope.
Another entry variation, called direct entry, employs no pneumoperitoneum. In this approach, the surgeon grabs the anterior abdominal wall, sharply elevating it, and directly thrusts the reusable or disposable trocar into the abdominal cavity.
An extensive review of entry techniques has been published elsewhere.1
Many complications arise from entry techniques and devices
A survey of Australian gynecologists about entry techniques found that 73% of respondents used a Veress needle and pneumoperitoneum for entry and that 83% used a location other than the infraumbilical site when periumbilical adhesions were suspected. Twenty-one percent had experienced a major retroperitoneal vascular injury, but 33% lacked a plan to manage such injuries.2
In their review of entry techniques, Vilos and colleagues asserted that Veress-needle insertion should be accompanied by pneumoperitoneal pressures of 20 to 30 mm Hg rather than a predetermined volume of CO2 gas.1 They also recommended insertion in the left upper quadrant when periumbilical adhesions are suspected or when insufflation at the umbilicus fails three times.
Newer entry devices include the optical-view trocar and the radially expanding trocar. The first consists of a plastic, conically tipped instrument that is optically clear. At least hypothetically, this device permits the surgeon to view each layer of the abdominal wall as he or she thrusts the device under “direct vision” into the abdominal cavity.
The radially expanding trocar is inserted over a Veress needle into the abdominal cavity. Its initial diameter is only 3 mm; once the instrument is in place, however, a blunt plastic trocar and sleeve are pushed into the mesh-like, radially expanding tube until it reaches 11 to 12 mm in diameter. The blunt trocar is then removed, leaving the plastic sheath and mesh material in place to accept the laparoscope. One key advantage of this device is the mesh component, which resists slippage or movement as the laparoscope is moved in and out of the sheath.
Vilos and colleagues concluded that open entry was neither superior nor inferior to other entry techniques and that direct entry without pneumoperitoneum may be as safe as Veress-needle techniques and associated with a lower risk of gas embolism. They also reported that shielded trocars are not associated with fewer visceral or vascular injuries and that visual-entry trocars lack superiority, compared with other devices, for the prevention of visceral or vascular injuries.1
Other review articles about entry techniques similarly found no objective evidence that any single technique is superior.3 However, data are conflicting on the safety of the optical trocar, compared with other trocars, with some data showing marginal advantages and others demonstrating no difference.4-6
Follow a few key entry guidelines
In 1990, Yuzpe reported a mail-in survey of 800 practicing ObGyns in Canada on the topic of pneumoperitoneum and trocar injuries.7 Of the 407 physicians who responded, 16.7% reported that the pneumoperitoneum needle caused a visceral or major vessel injury, and 16.5% attributed the injury to the primary trocar. Among 109 vessel injuries, 31 were caused by the pneumoperitoneum needle, and 28 of 104 injuries were caused by the primary trocar.
To be safe, Veress needle and primary trocar entry require critical attention to the angle and direction of the thrust relative to the abdominal cavity (FIGURE, page 24). For example, if the Veress needle or the sharp tip of the trocar deviate to the right or left of the midline during entry into the abdomen, injury to the iliac vessels is a clear risk.
Most laparoscopic surgeons stand on the left-hand side of the patient and face her feet. Trocar deviation for a right-handed person tends to vector to the right, especially when a twisting motion is utilized. Correct alignment of the primary trocar is straight down the middle of the lower abdomen on a virtual or real line drawn from the center of the navel to the center of the symphysis.
An entry angle of 45° to 60° will carry the needle or trocar toward the bladder or uterus and away from the aorta and left common iliac vein. In contrast, a 90° thrust will aim the device dangerously toward the great vessels. A slightly upward and right-sided deviation from the subumbilical entry will place the needle and trocar in the direction of the inferior vena cava and right common iliac vessels. A 90° entry with deviation to the left will position the entry device at the inferior mesenteric vessels and the left common iliac vessels.
Primary abdominal entry
An entry angle of 45° to 60°, regardless of whether a needle or trocar is used, will carry the device toward the bladder or uterus and away from the aorta and left common iliac vein.In a review of access complications associated with laparoscopy, including major vascular injuries, Philips and Amaral listed variables responsible for large-vessel injury; they also documented the incidence of such injuries associated with laparoscopic cholecystectomy.8 They recommended that the patient be placed in the Trendelenburg position and that the needle or trocar be inserted at a 45° angle that stays within the midline; they also concluded that the trocar should be placed when pneumoperitoneal pressures exceed 20 mm Hg. They advised against direct insertion in patients with a history of pelvic surgery as well as in thin patients.
Place secondary trocars under direct visualization
Secondary trocars should always be placed under direct, visually controlled entry and, at least hypothetically, should never injure any great vessel. Nevertheless, secondary trocars do sometimes cause injury, most often as a result of extreme lateral entry near the inguinal ligament. The vessels at risk are the external iliac artery and vein.
Injuries are also invariably associated with adhesiolysis and anatomic problems. Precise knowledge of pelvic anatomy is not only a requisite for pelvic surgery in general but also for laparoscopic surgery, in which the operative view is less clear than it is in open procedures.
Know the risks associated with operative tools
Suturing and knot tying are not easy maneuvers during laparoscopic procedures and add significant operative time. Although they are performed more easily when robotics is utilized, few gynecologists are skilled practitioners. As a result, accessory instruments have been developed to prevent and control bleeding during laparoscopic operations. These devices include monopolar and bipolar instruments, lasers, ultrasonic tools, and stapling devices.
Avoid monopolar electrosurgery
This modality should be avoided whenever possible because the risk of injury is significantly higher than with bipolar electrosurgery. The key disadvantages of monopolar energy are high-frequency leaks; low-frequency currents; direct, indirect, and capacitative coupling; and return-electrode failures. None of these problems are common with bipolar techniques.
However, all electrosurgical devices carry a risk of thermal injury through direct tissue contact and conduction of heat to neighboring tissues and structures.
A full discussion of the physics and tissue actions of electrosurgical devices may be found elsewhere.9
CO2 is the safest laser
A variety of lasers have been used in laparoscopic surgery. The neodymium–YAG, KTP-532, and CO2 lasers have been used most frequently for gynecologic operations.
Because of its wavelength, the CO2 laser is the safest device for intra-abdominal use. Advantages include precision and control. In addition, the CO2 laser is absorbed by water very effectively. As a result, hydrodissection techniques can facilitate effective backstopping of the laser beam in strategic locations, thereby preventing injury to surrounding structures.
Laser energy is not conducted through tissue in the same way that electrosurgical energy is conducted. Therefore, the laser is ideal for vaporizing endometrial implants and cutting adhesions.
Beware of heat generated by the ultrasonic shears
This device, known more commonly as the Harmonic Scalpel (Ethicon), employs high-frequency sound waves to shear and coagulate tissue and prevent bleeding. It does not require conduction through tissues but does require contact with tissues. Because friction produces heat, these devices can become hot enough to inflict unintended burns on tissues that are inadvertently touched by the hot tip or by heat transmitted from the operative site by thermal conduction.
Stapler may inadvertently involve adjacent structures
This laparoscopic device has the advantage of not requiring or emitting energy other than the mechanical force of the operator’s hand. Disadvantages associated with the stapler center on the inadvertent inclusion of other structures within the jaws of the instrument. In addition, the staplers themselves tend to be large and somewhat unwieldy in close quarters, adding to the risk of stapling nearby viscera.
Further information on the physics and actions of lasers, ultrasonic shears, and staplers is available.10,11
Obesity may increase the risk of major vessel injury
A recent study by Baggish found obesity to be a high-risk circumstance for major vessel injury.12 In the study, 22 of 31 women who sustained injury were overweight or obese, with a BMI ranging from 26 to 30 kg/m2.
Obesity increases the risk of major vessel injury because of the greater elasticity of the anterior abdominal wall. As force secondary to the downward thrust of the trocar is placed on the abdominal wall, it is pushed inward in the direction of the posterior wall. In contrast, thin women have rigid abdominal walls with minimal elasticity, so the force of the trocar thrust does not create significant displacement.
Baggish also found that disposable trocars accounted for 90% of major vascular injuries and that use of long trocars accounted for 43% of deaths.12
Injury and death are rare but real risks
In a multicenter study in France over 9 years, investigators reviewed 29,966 diagnostic and operative laparoscopic procedures and found a mortality rate of 3.33 deaths for every 100,000 laparoscopies and an overall complication rate of 4.64 complications for every 1,000 procedures.13 They found the complication rate to be significantly correlated with the complexity of the procedure (P = .0001). One in three complications (34.1%; n = 43) occurred during set-up, and one in four (28.6%) were not identified intraoperatively.13
The risk of great vessel injury associated with laparoscopy most frequently quoted is 0.5 injury for every 1,000 procedures.14 A multicenter study reported the prevalence of this complication to be 1.05 injuries per 1,000 procedures.15
The mortality rate associated with major vessel injury has been reported in several studies to range from 8% to 17%.14-17
Two articles measured the distance from various points on the anterior abdominal wall to the great retroperitoneal vessels during laparoscopic operations; they also measured the force required for the trocar to penetrate the abdominal wall.18,19 They found significant differences in the distance from the site of primary trocar insertion to the aorta and iliac vessels, depending on the BMI of the patient. In women with a BMI below 25 kg/m2, the mean distance to the aorta was 11.21 cm. In women with a BMI of 25 to 30, it was 14.14 cm, and in women with a BMI over 30, it was 15.14 cm. They also found variations in the mean thickness of the abdominal wall, which was 3.48 cm, 3.85 cm, and 5.05 cm in women with a BMI of less than 25, 25–30, and more than 30, respectively.
As for the force required for entry, investigators found that disposable cutting trocars can traverse the anterior abdominal wall with less force and less time, compared with reusable trocars and optical viewing devices.18,19
Another study measured the thickness of the abdominal wall and the distance to the great vessels by magnetic resonance imaging or computed tomography.20 However, this study was not performed during laparoscopy with pneumoperitoneum in place.
As previously mentioned, Baggish reported on 31 cases of major-vessel injury associated with laparoscopic operations involving 49 major-vessel injuries. Twenty-eight injuries occurred as a result of entry techniques: 26 occurred during primary trocar insertion, and two were related to secondary trocar thrusts.12 Four injuries and three deaths were associated with use of an 11-inch disposable trocar.
Of the injuries associated with primary trocar insertion, 10 occurred during direct insertion and 26 after creation of pneumoperitoneum. Open laparoscopy was performed in two cases.12 The TABLE details the number of vessels injured and the sites of injury in this study.
Seven women (23%) died as a direct result of venous injury. Collateral injury to other structures was observed in 16 cases. Blood loss ranged from 1,000 mL to 7,000 mL.12
Sites of major vessel injury in one study of gynecologic laparoscopy
| Site | Number of vascular injuries |
|---|---|
| Right iliac artery | 14 |
| Right iliac vein | 12 |
| Left iliac artery | 3 |
| Left iliac vein | 9 |
| Aorta | 4 |
| Vena cava | 2 |
| Mesenteric | 2 |
| Interior epigastric* | 2 |
| Other | 1 |
| Total injuries | 49 |
| Source: Baggish12 | |
Avoid these common errors
The most common errors in gynecologic laparoscopy include:
- delayed diagnosis
- failure to act on a visible retroperitoneal hematoma
- failure to cross-match adequate supplies of blood and blood products
- failure to adequately transfuse blood and blood products
- clamping the large damaged vessel
- opening the abdomen via Pfannenstiel incision
- failure to call for a vascular surgeon in a timely manner.
When a major vascular injury occurs, a well-informed surgeon will take the following measures:
- call for a vascular surgeon immediately. (Baggish found that there was a substantial delay in getting a vascular surgeon to the operating table in four of 31 cases.12)
- open the abdomen via a midline incision
- use a sponge stick to apply direct pressure to the bleeding vessel
- obtain an emergency type and cross-match and order a minimum of 6 U of blood plus fresh frozen plasma
- obtain a baseline complete blood count, platelet count, fibrinogen level, and test for fibrin-split products
- advise the anesthesiologist to seek additional help
- call for additional OR nursing personnel
- assign one circulator to run stats and record critical data.21-33
Prevention is the best strategy
As the opening case demonstrates, major vessel injury can occur without warning and cause cascading problems that can lead to permanent disability—even death. Because most serious vessel injuries occur during entry into the anterior abdominal wall, careful attention to entry techniques and the patient’s unique circumstances (obesity, presence of adhesions) can go a long way toward averting injury. Vigilance for the possibility of injury is also important throughout the procedure. When injury does occur, it is critical to call for help as soon as possible and to have safeguards in place to manage it.
Tune in again in October 2012 for Part 2 of this series, which offers insight into gastrointestinal and urinary tract injuries during laparoscopy and offers valuable guidance on avoiding and managing related complications.
We want to hear from you! Tell us what you think.
 | Dr. Baggish discusses safe abdominal entry techniques |
Michael Baggish, MD
Dr. Baggish practices Obstetrics and Gynecology at The Women’s Center at Saint Helena Hospital in Saint Helena, California. He also serves as Professor of Obstetrics and Gynecology at the University of California, San Francisco, and as Emeritus Chairman and Residency Director, Department of Obstetrics and Gynecology, Good Samaritan Hospital, Cincinnati, Ohio.
Dr. Baggish reports no financial relationships relevant to this article.
| Dr. Baggish discusses safe abdominal entry techniques |
Michael Baggish, MD
Dr. Baggish practices Obstetrics and Gynecology at The Women’s Center at Saint Helena Hospital in Saint Helena, California. He also serves as Professor of Obstetrics and Gynecology at the University of California, San Francisco, and as Emeritus Chairman and Residency Director, Department of Obstetrics and Gynecology, Good Samaritan Hospital, Cincinnati, Ohio.
Dr. Baggish reports no financial relationships relevant to this article.
| Dr. Baggish discusses safe abdominal entry techniques |
Michael Baggish, MD
Dr. Baggish practices Obstetrics and Gynecology at The Women’s Center at Saint Helena Hospital in Saint Helena, California. He also serves as Professor of Obstetrics and Gynecology at the University of California, San Francisco, and as Emeritus Chairman and Residency Director, Department of Obstetrics and Gynecology, Good Samaritan Hospital, Cincinnati, Ohio.
Dr. Baggish reports no financial relationships relevant to this article.
Update: Minimally invasive Surgery
Amy Garcia, MD (April 2012)
10 practical, evidence-based suggestions to improve your minimally invasive surgical skills now
Catherine A. Matthews, MD (April 2011)
CASE: Abdominal entry leads to life-threatening injury
A 50-year-old woman with a BMI of 25 kg/m2, a strong family history of breast and ovarian cancer, and a confirmed BRCA mutation was scheduled for prophylactic bilateral salpingo-oophorectomy via robotic laparoscopy on November 26, 2009. At the time of the procedure, the gynecologic surgeon selected a site for the camera trocar that was several centimeters above the umbilicus. After making a transverse incision, he inserted a Veress needle and insufflated the abdomen with CO2 gas until intra-abdominal pressure reached 17 mm Hg. He then thrust an 11-inch disposable trocar through the anterior abdominal wall, attached the camera to the laparoscope, confirmed proper intraperitoneal placement, and inserted two additional trocars under direct vision.
Shortly after these actions, the anesthesiologist reported that the patient’s blood pressure had dropped precipitously, along with end tidal CO2. The surgeon examined the peritoneal cavity and discovered blood in the right paracolic gutter. The anesthesiologist advised the surgeon that he could no longer detect the patient’s blood pressure; electrocardiography revealed pulseless electrical activity.
The surgical team began chest compressions, evacuated the pneumoperitoneum, and removed all trocars. Blood was noted on the camera trocar, and the device was secured by the OR staff. The surgeon performed an emergent laparotomy, making the incision within 4 minutes of the beginning of CPR. Exploration revealed a large retroperitoneal hematoma above the area of the aortic bifurcation and inferior vena cava.
General and vascular surgeons were called. The general surgeon opened the retroperitoneum and found an extreme amount of clotted and unclotted blood. The vascular surgeon described the initial injury as a 1.5-cm laceration of the distal aorta, just above the bifurcation. A cell saver was requested and recorded blood loss of 12,000 mL.
The vascular surgeon clamped the aorta proximally; he also clamped both common iliac arteries. He then repaired the lacerations on the aorta using 5-0 Prolene suture (Ethicon). The aorta was significantly narrowed, however, so the surgeon decided to replace the distal aorta, which he then resected and repaired using a 14-mm Dacron graft (DuPont).
Further inspection revealed continuing retroperitoneal bleeding. The vascular surgeon found and repaired a laceration of the inferior mesenteric vein. He also clipped multiple small veins to stop bleeding.
When a hole in the transverse colon was identified, the general surgeon—who had left the operating table—rescrubbed to repair it. He also discovered an injury to the mesentery of the transverse colon and repaired both wounds, resecting the perforated segment. The divided, stapled colon was dropped back into the abdomen because the bowel was dusky. Despite an epinephrine drip, the patient was hypotensive and coagulopathic. The abdomen was packed and covered with sterile cassette film, with towels covering the open wound.
The patient was taken to the postanesthesia care unit in guarded condition and was subsequently transferred to the ICU, where her blood pressure dropped again. She was returned to the OR, where the packs were removed and a bleeding right common iliac artery was repaired using 5-0 Prolene suture. The next day, she underwent bilateral salpingo-oophorectomy with a transverse colon colostomy.
Because of the colon injury, the vascular surgeon believed that the Dacron graft had been contaminated. On December 1, the graft was taken down, a left femoral-vein autograft was harvested, and a reconstructive conduit was created for the terminal aorta. The patient underwent three additional procedures to place mesh into the abdominal wall. When the mesh became infected, it was removed.
The patient remained in the hospital for 1 month, after which she was transferred to a long-term care facility. She suffered permanent neurologic injuries because of prolonged hypoxia and continues to require supportive care.
How could this catastrophe have been avoided?
Traumatic injury to the great retroperitoneal vessels is an emergent and life-threatening event. During gynecologic laparoscopy, it is most likely to occur during entry into the anterior abdominal wall.
Most laparoscopic procedures require entry into the anterior abdominal wall for placement of a trocar and a sleeve that serves as a portal for insertion of the endoscope. Secondary ports provide entry points for manipulative and operative tools.
The most critical entry point is primary placement of the viewing device. Secondary trocars are always inserted under direct visualization; therefore, they carry a lower risk of inflicting injury to underlying viscera and vessels.
Practice safe entry
In the early days of laparoscopy, only one method of entry existed. Over time, however, several other techniques have been devised.
The initial method—still widely utilized—is known as the closed or blind technique. The surgeon creates a pneumoperitoneum with the use of a needle that is 18 gauge to 2.5 mm in diameter; the needle is placed through a subumbilical incision. Once intraperitoneal placement is confirmed, CO2 gas is infused into the peritoneal cavity until the abdomen is tympanic to percussion (usually at pressures of 14 to 18 mm Hg).
Next, the surgeon aims the trocar toward the uterus at a 45° angle, maintaining the device in the midline. Entry is confirmed by opening the trocar’s trap-door valve and witnessing a rush of CO2 gas.
Another entry technique—the open technique—is used almost universally by general surgeons. The procedure is a type of microlaparotomy. After making the subumbilical incision, the fascia of the abdominal wall is pierced and the peritoneum is grasped and opened bluntly or sharply. Once the edges of the peritoneum are secured, a blunt trocar (Hasson trocar) is inserted. Then the trocar is removed, leaving the sleeve in place to accept the laparoscope.
Another entry variation, called direct entry, employs no pneumoperitoneum. In this approach, the surgeon grabs the anterior abdominal wall, sharply elevating it, and directly thrusts the reusable or disposable trocar into the abdominal cavity.
An extensive review of entry techniques has been published elsewhere.1
Many complications arise from entry techniques and devices
A survey of Australian gynecologists about entry techniques found that 73% of respondents used a Veress needle and pneumoperitoneum for entry and that 83% used a location other than the infraumbilical site when periumbilical adhesions were suspected. Twenty-one percent had experienced a major retroperitoneal vascular injury, but 33% lacked a plan to manage such injuries.2
In their review of entry techniques, Vilos and colleagues asserted that Veress-needle insertion should be accompanied by pneumoperitoneal pressures of 20 to 30 mm Hg rather than a predetermined volume of CO2 gas.1 They also recommended insertion in the left upper quadrant when periumbilical adhesions are suspected or when insufflation at the umbilicus fails three times.
Newer entry devices include the optical-view trocar and the radially expanding trocar. The first consists of a plastic, conically tipped instrument that is optically clear. At least hypothetically, this device permits the surgeon to view each layer of the abdominal wall as he or she thrusts the device under “direct vision” into the abdominal cavity.
The radially expanding trocar is inserted over a Veress needle into the abdominal cavity. Its initial diameter is only 3 mm; once the instrument is in place, however, a blunt plastic trocar and sleeve are pushed into the mesh-like, radially expanding tube until it reaches 11 to 12 mm in diameter. The blunt trocar is then removed, leaving the plastic sheath and mesh material in place to accept the laparoscope. One key advantage of this device is the mesh component, which resists slippage or movement as the laparoscope is moved in and out of the sheath.
Vilos and colleagues concluded that open entry was neither superior nor inferior to other entry techniques and that direct entry without pneumoperitoneum may be as safe as Veress-needle techniques and associated with a lower risk of gas embolism. They also reported that shielded trocars are not associated with fewer visceral or vascular injuries and that visual-entry trocars lack superiority, compared with other devices, for the prevention of visceral or vascular injuries.1
Other review articles about entry techniques similarly found no objective evidence that any single technique is superior.3 However, data are conflicting on the safety of the optical trocar, compared with other trocars, with some data showing marginal advantages and others demonstrating no difference.4-6
Follow a few key entry guidelines
In 1990, Yuzpe reported a mail-in survey of 800 practicing ObGyns in Canada on the topic of pneumoperitoneum and trocar injuries.7 Of the 407 physicians who responded, 16.7% reported that the pneumoperitoneum needle caused a visceral or major vessel injury, and 16.5% attributed the injury to the primary trocar. Among 109 vessel injuries, 31 were caused by the pneumoperitoneum needle, and 28 of 104 injuries were caused by the primary trocar.
To be safe, Veress needle and primary trocar entry require critical attention to the angle and direction of the thrust relative to the abdominal cavity (FIGURE, page 24). For example, if the Veress needle or the sharp tip of the trocar deviate to the right or left of the midline during entry into the abdomen, injury to the iliac vessels is a clear risk.
Most laparoscopic surgeons stand on the left-hand side of the patient and face her feet. Trocar deviation for a right-handed person tends to vector to the right, especially when a twisting motion is utilized. Correct alignment of the primary trocar is straight down the middle of the lower abdomen on a virtual or real line drawn from the center of the navel to the center of the symphysis.
An entry angle of 45° to 60° will carry the needle or trocar toward the bladder or uterus and away from the aorta and left common iliac vein. In contrast, a 90° thrust will aim the device dangerously toward the great vessels. A slightly upward and right-sided deviation from the subumbilical entry will place the needle and trocar in the direction of the inferior vena cava and right common iliac vessels. A 90° entry with deviation to the left will position the entry device at the inferior mesenteric vessels and the left common iliac vessels.
Primary abdominal entry
An entry angle of 45° to 60°, regardless of whether a needle or trocar is used, will carry the device toward the bladder or uterus and away from the aorta and left common iliac vein.In a review of access complications associated with laparoscopy, including major vascular injuries, Philips and Amaral listed variables responsible for large-vessel injury; they also documented the incidence of such injuries associated with laparoscopic cholecystectomy.8 They recommended that the patient be placed in the Trendelenburg position and that the needle or trocar be inserted at a 45° angle that stays within the midline; they also concluded that the trocar should be placed when pneumoperitoneal pressures exceed 20 mm Hg. They advised against direct insertion in patients with a history of pelvic surgery as well as in thin patients.
Place secondary trocars under direct visualization
Secondary trocars should always be placed under direct, visually controlled entry and, at least hypothetically, should never injure any great vessel. Nevertheless, secondary trocars do sometimes cause injury, most often as a result of extreme lateral entry near the inguinal ligament. The vessels at risk are the external iliac artery and vein.
Injuries are also invariably associated with adhesiolysis and anatomic problems. Precise knowledge of pelvic anatomy is not only a requisite for pelvic surgery in general but also for laparoscopic surgery, in which the operative view is less clear than it is in open procedures.
Know the risks associated with operative tools
Suturing and knot tying are not easy maneuvers during laparoscopic procedures and add significant operative time. Although they are performed more easily when robotics is utilized, few gynecologists are skilled practitioners. As a result, accessory instruments have been developed to prevent and control bleeding during laparoscopic operations. These devices include monopolar and bipolar instruments, lasers, ultrasonic tools, and stapling devices.
Avoid monopolar electrosurgery
This modality should be avoided whenever possible because the risk of injury is significantly higher than with bipolar electrosurgery. The key disadvantages of monopolar energy are high-frequency leaks; low-frequency currents; direct, indirect, and capacitative coupling; and return-electrode failures. None of these problems are common with bipolar techniques.
However, all electrosurgical devices carry a risk of thermal injury through direct tissue contact and conduction of heat to neighboring tissues and structures.
A full discussion of the physics and tissue actions of electrosurgical devices may be found elsewhere.9
CO2 is the safest laser
A variety of lasers have been used in laparoscopic surgery. The neodymium–YAG, KTP-532, and CO2 lasers have been used most frequently for gynecologic operations.
Because of its wavelength, the CO2 laser is the safest device for intra-abdominal use. Advantages include precision and control. In addition, the CO2 laser is absorbed by water very effectively. As a result, hydrodissection techniques can facilitate effective backstopping of the laser beam in strategic locations, thereby preventing injury to surrounding structures.
Laser energy is not conducted through tissue in the same way that electrosurgical energy is conducted. Therefore, the laser is ideal for vaporizing endometrial implants and cutting adhesions.
Beware of heat generated by the ultrasonic shears
This device, known more commonly as the Harmonic Scalpel (Ethicon), employs high-frequency sound waves to shear and coagulate tissue and prevent bleeding. It does not require conduction through tissues but does require contact with tissues. Because friction produces heat, these devices can become hot enough to inflict unintended burns on tissues that are inadvertently touched by the hot tip or by heat transmitted from the operative site by thermal conduction.
Stapler may inadvertently involve adjacent structures
This laparoscopic device has the advantage of not requiring or emitting energy other than the mechanical force of the operator’s hand. Disadvantages associated with the stapler center on the inadvertent inclusion of other structures within the jaws of the instrument. In addition, the staplers themselves tend to be large and somewhat unwieldy in close quarters, adding to the risk of stapling nearby viscera.
Further information on the physics and actions of lasers, ultrasonic shears, and staplers is available.10,11
Obesity may increase the risk of major vessel injury
A recent study by Baggish found obesity to be a high-risk circumstance for major vessel injury.12 In the study, 22 of 31 women who sustained injury were overweight or obese, with a BMI ranging from 26 to 30 kg/m2.
Obesity increases the risk of major vessel injury because of the greater elasticity of the anterior abdominal wall. As force secondary to the downward thrust of the trocar is placed on the abdominal wall, it is pushed inward in the direction of the posterior wall. In contrast, thin women have rigid abdominal walls with minimal elasticity, so the force of the trocar thrust does not create significant displacement.
Baggish also found that disposable trocars accounted for 90% of major vascular injuries and that use of long trocars accounted for 43% of deaths.12
Injury and death are rare but real risks
In a multicenter study in France over 9 years, investigators reviewed 29,966 diagnostic and operative laparoscopic procedures and found a mortality rate of 3.33 deaths for every 100,000 laparoscopies and an overall complication rate of 4.64 complications for every 1,000 procedures.13 They found the complication rate to be significantly correlated with the complexity of the procedure (P = .0001). One in three complications (34.1%; n = 43) occurred during set-up, and one in four (28.6%) were not identified intraoperatively.13
The risk of great vessel injury associated with laparoscopy most frequently quoted is 0.5 injury for every 1,000 procedures.14 A multicenter study reported the prevalence of this complication to be 1.05 injuries per 1,000 procedures.15
The mortality rate associated with major vessel injury has been reported in several studies to range from 8% to 17%.14-17
Two articles measured the distance from various points on the anterior abdominal wall to the great retroperitoneal vessels during laparoscopic operations; they also measured the force required for the trocar to penetrate the abdominal wall.18,19 They found significant differences in the distance from the site of primary trocar insertion to the aorta and iliac vessels, depending on the BMI of the patient. In women with a BMI below 25 kg/m2, the mean distance to the aorta was 11.21 cm. In women with a BMI of 25 to 30, it was 14.14 cm, and in women with a BMI over 30, it was 15.14 cm. They also found variations in the mean thickness of the abdominal wall, which was 3.48 cm, 3.85 cm, and 5.05 cm in women with a BMI of less than 25, 25–30, and more than 30, respectively.
As for the force required for entry, investigators found that disposable cutting trocars can traverse the anterior abdominal wall with less force and less time, compared with reusable trocars and optical viewing devices.18,19
Another study measured the thickness of the abdominal wall and the distance to the great vessels by magnetic resonance imaging or computed tomography.20 However, this study was not performed during laparoscopy with pneumoperitoneum in place.
As previously mentioned, Baggish reported on 31 cases of major-vessel injury associated with laparoscopic operations involving 49 major-vessel injuries. Twenty-eight injuries occurred as a result of entry techniques: 26 occurred during primary trocar insertion, and two were related to secondary trocar thrusts.12 Four injuries and three deaths were associated with use of an 11-inch disposable trocar.
Of the injuries associated with primary trocar insertion, 10 occurred during direct insertion and 26 after creation of pneumoperitoneum. Open laparoscopy was performed in two cases.12 The TABLE details the number of vessels injured and the sites of injury in this study.
Seven women (23%) died as a direct result of venous injury. Collateral injury to other structures was observed in 16 cases. Blood loss ranged from 1,000 mL to 7,000 mL.12
Sites of major vessel injury in one study of gynecologic laparoscopy
| Site | Number of vascular injuries |
|---|---|
| Right iliac artery | 14 |
| Right iliac vein | 12 |
| Left iliac artery | 3 |
| Left iliac vein | 9 |
| Aorta | 4 |
| Vena cava | 2 |
| Mesenteric | 2 |
| Interior epigastric* | 2 |
| Other | 1 |
| Total injuries | 49 |
| Source: Baggish12 | |
Avoid these common errors
The most common errors in gynecologic laparoscopy include:
- delayed diagnosis
- failure to act on a visible retroperitoneal hematoma
- failure to cross-match adequate supplies of blood and blood products
- failure to adequately transfuse blood and blood products
- clamping the large damaged vessel
- opening the abdomen via Pfannenstiel incision
- failure to call for a vascular surgeon in a timely manner.
When a major vascular injury occurs, a well-informed surgeon will take the following measures:
- call for a vascular surgeon immediately. (Baggish found that there was a substantial delay in getting a vascular surgeon to the operating table in four of 31 cases.12)
- open the abdomen via a midline incision
- use a sponge stick to apply direct pressure to the bleeding vessel
- obtain an emergency type and cross-match and order a minimum of 6 U of blood plus fresh frozen plasma
- obtain a baseline complete blood count, platelet count, fibrinogen level, and test for fibrin-split products
- advise the anesthesiologist to seek additional help
- call for additional OR nursing personnel
- assign one circulator to run stats and record critical data.21-33
Prevention is the best strategy
As the opening case demonstrates, major vessel injury can occur without warning and cause cascading problems that can lead to permanent disability—even death. Because most serious vessel injuries occur during entry into the anterior abdominal wall, careful attention to entry techniques and the patient’s unique circumstances (obesity, presence of adhesions) can go a long way toward averting injury. Vigilance for the possibility of injury is also important throughout the procedure. When injury does occur, it is critical to call for help as soon as possible and to have safeguards in place to manage it.
Tune in again in October 2012 for Part 2 of this series, which offers insight into gastrointestinal and urinary tract injuries during laparoscopy and offers valuable guidance on avoiding and managing related complications.
We want to hear from you! Tell us what you think.
Update: Minimally invasive Surgery
Amy Garcia, MD (April 2012)
10 practical, evidence-based suggestions to improve your minimally invasive surgical skills now
Catherine A. Matthews, MD (April 2011)
CASE: Abdominal entry leads to life-threatening injury
A 50-year-old woman with a BMI of 25 kg/m2, a strong family history of breast and ovarian cancer, and a confirmed BRCA mutation was scheduled for prophylactic bilateral salpingo-oophorectomy via robotic laparoscopy on November 26, 2009. At the time of the procedure, the gynecologic surgeon selected a site for the camera trocar that was several centimeters above the umbilicus. After making a transverse incision, he inserted a Veress needle and insufflated the abdomen with CO2 gas until intra-abdominal pressure reached 17 mm Hg. He then thrust an 11-inch disposable trocar through the anterior abdominal wall, attached the camera to the laparoscope, confirmed proper intraperitoneal placement, and inserted two additional trocars under direct vision.
Shortly after these actions, the anesthesiologist reported that the patient’s blood pressure had dropped precipitously, along with end tidal CO2. The surgeon examined the peritoneal cavity and discovered blood in the right paracolic gutter. The anesthesiologist advised the surgeon that he could no longer detect the patient’s blood pressure; electrocardiography revealed pulseless electrical activity.
The surgical team began chest compressions, evacuated the pneumoperitoneum, and removed all trocars. Blood was noted on the camera trocar, and the device was secured by the OR staff. The surgeon performed an emergent laparotomy, making the incision within 4 minutes of the beginning of CPR. Exploration revealed a large retroperitoneal hematoma above the area of the aortic bifurcation and inferior vena cava.
General and vascular surgeons were called. The general surgeon opened the retroperitoneum and found an extreme amount of clotted and unclotted blood. The vascular surgeon described the initial injury as a 1.5-cm laceration of the distal aorta, just above the bifurcation. A cell saver was requested and recorded blood loss of 12,000 mL.
The vascular surgeon clamped the aorta proximally; he also clamped both common iliac arteries. He then repaired the lacerations on the aorta using 5-0 Prolene suture (Ethicon). The aorta was significantly narrowed, however, so the surgeon decided to replace the distal aorta, which he then resected and repaired using a 14-mm Dacron graft (DuPont).
Further inspection revealed continuing retroperitoneal bleeding. The vascular surgeon found and repaired a laceration of the inferior mesenteric vein. He also clipped multiple small veins to stop bleeding.
When a hole in the transverse colon was identified, the general surgeon—who had left the operating table—rescrubbed to repair it. He also discovered an injury to the mesentery of the transverse colon and repaired both wounds, resecting the perforated segment. The divided, stapled colon was dropped back into the abdomen because the bowel was dusky. Despite an epinephrine drip, the patient was hypotensive and coagulopathic. The abdomen was packed and covered with sterile cassette film, with towels covering the open wound.
The patient was taken to the postanesthesia care unit in guarded condition and was subsequently transferred to the ICU, where her blood pressure dropped again. She was returned to the OR, where the packs were removed and a bleeding right common iliac artery was repaired using 5-0 Prolene suture. The next day, she underwent bilateral salpingo-oophorectomy with a transverse colon colostomy.
Because of the colon injury, the vascular surgeon believed that the Dacron graft had been contaminated. On December 1, the graft was taken down, a left femoral-vein autograft was harvested, and a reconstructive conduit was created for the terminal aorta. The patient underwent three additional procedures to place mesh into the abdominal wall. When the mesh became infected, it was removed.
The patient remained in the hospital for 1 month, after which she was transferred to a long-term care facility. She suffered permanent neurologic injuries because of prolonged hypoxia and continues to require supportive care.
How could this catastrophe have been avoided?
Traumatic injury to the great retroperitoneal vessels is an emergent and life-threatening event. During gynecologic laparoscopy, it is most likely to occur during entry into the anterior abdominal wall.
Most laparoscopic procedures require entry into the anterior abdominal wall for placement of a trocar and a sleeve that serves as a portal for insertion of the endoscope. Secondary ports provide entry points for manipulative and operative tools.
The most critical entry point is primary placement of the viewing device. Secondary trocars are always inserted under direct visualization; therefore, they carry a lower risk of inflicting injury to underlying viscera and vessels.
Practice safe entry
In the early days of laparoscopy, only one method of entry existed. Over time, however, several other techniques have been devised.
The initial method—still widely utilized—is known as the closed or blind technique. The surgeon creates a pneumoperitoneum with the use of a needle that is 18 gauge to 2.5 mm in diameter; the needle is placed through a subumbilical incision. Once intraperitoneal placement is confirmed, CO2 gas is infused into the peritoneal cavity until the abdomen is tympanic to percussion (usually at pressures of 14 to 18 mm Hg).
Next, the surgeon aims the trocar toward the uterus at a 45° angle, maintaining the device in the midline. Entry is confirmed by opening the trocar’s trap-door valve and witnessing a rush of CO2 gas.
Another entry technique—the open technique—is used almost universally by general surgeons. The procedure is a type of microlaparotomy. After making the subumbilical incision, the fascia of the abdominal wall is pierced and the peritoneum is grasped and opened bluntly or sharply. Once the edges of the peritoneum are secured, a blunt trocar (Hasson trocar) is inserted. Then the trocar is removed, leaving the sleeve in place to accept the laparoscope.
Another entry variation, called direct entry, employs no pneumoperitoneum. In this approach, the surgeon grabs the anterior abdominal wall, sharply elevating it, and directly thrusts the reusable or disposable trocar into the abdominal cavity.
An extensive review of entry techniques has been published elsewhere.1
Many complications arise from entry techniques and devices
A survey of Australian gynecologists about entry techniques found that 73% of respondents used a Veress needle and pneumoperitoneum for entry and that 83% used a location other than the infraumbilical site when periumbilical adhesions were suspected. Twenty-one percent had experienced a major retroperitoneal vascular injury, but 33% lacked a plan to manage such injuries.2
In their review of entry techniques, Vilos and colleagues asserted that Veress-needle insertion should be accompanied by pneumoperitoneal pressures of 20 to 30 mm Hg rather than a predetermined volume of CO2 gas.1 They also recommended insertion in the left upper quadrant when periumbilical adhesions are suspected or when insufflation at the umbilicus fails three times.
Newer entry devices include the optical-view trocar and the radially expanding trocar. The first consists of a plastic, conically tipped instrument that is optically clear. At least hypothetically, this device permits the surgeon to view each layer of the abdominal wall as he or she thrusts the device under “direct vision” into the abdominal cavity.
The radially expanding trocar is inserted over a Veress needle into the abdominal cavity. Its initial diameter is only 3 mm; once the instrument is in place, however, a blunt plastic trocar and sleeve are pushed into the mesh-like, radially expanding tube until it reaches 11 to 12 mm in diameter. The blunt trocar is then removed, leaving the plastic sheath and mesh material in place to accept the laparoscope. One key advantage of this device is the mesh component, which resists slippage or movement as the laparoscope is moved in and out of the sheath.
Vilos and colleagues concluded that open entry was neither superior nor inferior to other entry techniques and that direct entry without pneumoperitoneum may be as safe as Veress-needle techniques and associated with a lower risk of gas embolism. They also reported that shielded trocars are not associated with fewer visceral or vascular injuries and that visual-entry trocars lack superiority, compared with other devices, for the prevention of visceral or vascular injuries.1
Other review articles about entry techniques similarly found no objective evidence that any single technique is superior.3 However, data are conflicting on the safety of the optical trocar, compared with other trocars, with some data showing marginal advantages and others demonstrating no difference.4-6
Follow a few key entry guidelines
In 1990, Yuzpe reported a mail-in survey of 800 practicing ObGyns in Canada on the topic of pneumoperitoneum and trocar injuries.7 Of the 407 physicians who responded, 16.7% reported that the pneumoperitoneum needle caused a visceral or major vessel injury, and 16.5% attributed the injury to the primary trocar. Among 109 vessel injuries, 31 were caused by the pneumoperitoneum needle, and 28 of 104 injuries were caused by the primary trocar.
To be safe, Veress needle and primary trocar entry require critical attention to the angle and direction of the thrust relative to the abdominal cavity (FIGURE, page 24). For example, if the Veress needle or the sharp tip of the trocar deviate to the right or left of the midline during entry into the abdomen, injury to the iliac vessels is a clear risk.
Most laparoscopic surgeons stand on the left-hand side of the patient and face her feet. Trocar deviation for a right-handed person tends to vector to the right, especially when a twisting motion is utilized. Correct alignment of the primary trocar is straight down the middle of the lower abdomen on a virtual or real line drawn from the center of the navel to the center of the symphysis.
An entry angle of 45° to 60° will carry the needle or trocar toward the bladder or uterus and away from the aorta and left common iliac vein. In contrast, a 90° thrust will aim the device dangerously toward the great vessels. A slightly upward and right-sided deviation from the subumbilical entry will place the needle and trocar in the direction of the inferior vena cava and right common iliac vessels. A 90° entry with deviation to the left will position the entry device at the inferior mesenteric vessels and the left common iliac vessels.
Primary abdominal entry
An entry angle of 45° to 60°, regardless of whether a needle or trocar is used, will carry the device toward the bladder or uterus and away from the aorta and left common iliac vein.In a review of access complications associated with laparoscopy, including major vascular injuries, Philips and Amaral listed variables responsible for large-vessel injury; they also documented the incidence of such injuries associated with laparoscopic cholecystectomy.8 They recommended that the patient be placed in the Trendelenburg position and that the needle or trocar be inserted at a 45° angle that stays within the midline; they also concluded that the trocar should be placed when pneumoperitoneal pressures exceed 20 mm Hg. They advised against direct insertion in patients with a history of pelvic surgery as well as in thin patients.
Place secondary trocars under direct visualization
Secondary trocars should always be placed under direct, visually controlled entry and, at least hypothetically, should never injure any great vessel. Nevertheless, secondary trocars do sometimes cause injury, most often as a result of extreme lateral entry near the inguinal ligament. The vessels at risk are the external iliac artery and vein.
Injuries are also invariably associated with adhesiolysis and anatomic problems. Precise knowledge of pelvic anatomy is not only a requisite for pelvic surgery in general but also for laparoscopic surgery, in which the operative view is less clear than it is in open procedures.
Know the risks associated with operative tools
Suturing and knot tying are not easy maneuvers during laparoscopic procedures and add significant operative time. Although they are performed more easily when robotics is utilized, few gynecologists are skilled practitioners. As a result, accessory instruments have been developed to prevent and control bleeding during laparoscopic operations. These devices include monopolar and bipolar instruments, lasers, ultrasonic tools, and stapling devices.
Avoid monopolar electrosurgery
This modality should be avoided whenever possible because the risk of injury is significantly higher than with bipolar electrosurgery. The key disadvantages of monopolar energy are high-frequency leaks; low-frequency currents; direct, indirect, and capacitative coupling; and return-electrode failures. None of these problems are common with bipolar techniques.
However, all electrosurgical devices carry a risk of thermal injury through direct tissue contact and conduction of heat to neighboring tissues and structures.
A full discussion of the physics and tissue actions of electrosurgical devices may be found elsewhere.9
CO2 is the safest laser
A variety of lasers have been used in laparoscopic surgery. The neodymium–YAG, KTP-532, and CO2 lasers have been used most frequently for gynecologic operations.
Because of its wavelength, the CO2 laser is the safest device for intra-abdominal use. Advantages include precision and control. In addition, the CO2 laser is absorbed by water very effectively. As a result, hydrodissection techniques can facilitate effective backstopping of the laser beam in strategic locations, thereby preventing injury to surrounding structures.
Laser energy is not conducted through tissue in the same way that electrosurgical energy is conducted. Therefore, the laser is ideal for vaporizing endometrial implants and cutting adhesions.
Beware of heat generated by the ultrasonic shears
This device, known more commonly as the Harmonic Scalpel (Ethicon), employs high-frequency sound waves to shear and coagulate tissue and prevent bleeding. It does not require conduction through tissues but does require contact with tissues. Because friction produces heat, these devices can become hot enough to inflict unintended burns on tissues that are inadvertently touched by the hot tip or by heat transmitted from the operative site by thermal conduction.
Stapler may inadvertently involve adjacent structures
This laparoscopic device has the advantage of not requiring or emitting energy other than the mechanical force of the operator’s hand. Disadvantages associated with the stapler center on the inadvertent inclusion of other structures within the jaws of the instrument. In addition, the staplers themselves tend to be large and somewhat unwieldy in close quarters, adding to the risk of stapling nearby viscera.
Further information on the physics and actions of lasers, ultrasonic shears, and staplers is available.10,11
Obesity may increase the risk of major vessel injury
A recent study by Baggish found obesity to be a high-risk circumstance for major vessel injury.12 In the study, 22 of 31 women who sustained injury were overweight or obese, with a BMI ranging from 26 to 30 kg/m2.
Obesity increases the risk of major vessel injury because of the greater elasticity of the anterior abdominal wall. As force secondary to the downward thrust of the trocar is placed on the abdominal wall, it is pushed inward in the direction of the posterior wall. In contrast, thin women have rigid abdominal walls with minimal elasticity, so the force of the trocar thrust does not create significant displacement.
Baggish also found that disposable trocars accounted for 90% of major vascular injuries and that use of long trocars accounted for 43% of deaths.12
Injury and death are rare but real risks
In a multicenter study in France over 9 years, investigators reviewed 29,966 diagnostic and operative laparoscopic procedures and found a mortality rate of 3.33 deaths for every 100,000 laparoscopies and an overall complication rate of 4.64 complications for every 1,000 procedures.13 They found the complication rate to be significantly correlated with the complexity of the procedure (P = .0001). One in three complications (34.1%; n = 43) occurred during set-up, and one in four (28.6%) were not identified intraoperatively.13
The risk of great vessel injury associated with laparoscopy most frequently quoted is 0.5 injury for every 1,000 procedures.14 A multicenter study reported the prevalence of this complication to be 1.05 injuries per 1,000 procedures.15
The mortality rate associated with major vessel injury has been reported in several studies to range from 8% to 17%.14-17
Two articles measured the distance from various points on the anterior abdominal wall to the great retroperitoneal vessels during laparoscopic operations; they also measured the force required for the trocar to penetrate the abdominal wall.18,19 They found significant differences in the distance from the site of primary trocar insertion to the aorta and iliac vessels, depending on the BMI of the patient. In women with a BMI below 25 kg/m2, the mean distance to the aorta was 11.21 cm. In women with a BMI of 25 to 30, it was 14.14 cm, and in women with a BMI over 30, it was 15.14 cm. They also found variations in the mean thickness of the abdominal wall, which was 3.48 cm, 3.85 cm, and 5.05 cm in women with a BMI of less than 25, 25–30, and more than 30, respectively.
As for the force required for entry, investigators found that disposable cutting trocars can traverse the anterior abdominal wall with less force and less time, compared with reusable trocars and optical viewing devices.18,19
Another study measured the thickness of the abdominal wall and the distance to the great vessels by magnetic resonance imaging or computed tomography.20 However, this study was not performed during laparoscopy with pneumoperitoneum in place.
As previously mentioned, Baggish reported on 31 cases of major-vessel injury associated with laparoscopic operations involving 49 major-vessel injuries. Twenty-eight injuries occurred as a result of entry techniques: 26 occurred during primary trocar insertion, and two were related to secondary trocar thrusts.12 Four injuries and three deaths were associated with use of an 11-inch disposable trocar.
Of the injuries associated with primary trocar insertion, 10 occurred during direct insertion and 26 after creation of pneumoperitoneum. Open laparoscopy was performed in two cases.12 The TABLE details the number of vessels injured and the sites of injury in this study.
Seven women (23%) died as a direct result of venous injury. Collateral injury to other structures was observed in 16 cases. Blood loss ranged from 1,000 mL to 7,000 mL.12
Sites of major vessel injury in one study of gynecologic laparoscopy
| Site | Number of vascular injuries |
|---|---|
| Right iliac artery | 14 |
| Right iliac vein | 12 |
| Left iliac artery | 3 |
| Left iliac vein | 9 |
| Aorta | 4 |
| Vena cava | 2 |
| Mesenteric | 2 |
| Interior epigastric* | 2 |
| Other | 1 |
| Total injuries | 49 |
| Source: Baggish12 | |
Avoid these common errors
The most common errors in gynecologic laparoscopy include:
- delayed diagnosis
- failure to act on a visible retroperitoneal hematoma
- failure to cross-match adequate supplies of blood and blood products
- failure to adequately transfuse blood and blood products
- clamping the large damaged vessel
- opening the abdomen via Pfannenstiel incision
- failure to call for a vascular surgeon in a timely manner.
When a major vascular injury occurs, a well-informed surgeon will take the following measures:
- call for a vascular surgeon immediately. (Baggish found that there was a substantial delay in getting a vascular surgeon to the operating table in four of 31 cases.12)
- open the abdomen via a midline incision
- use a sponge stick to apply direct pressure to the bleeding vessel
- obtain an emergency type and cross-match and order a minimum of 6 U of blood plus fresh frozen plasma
- obtain a baseline complete blood count, platelet count, fibrinogen level, and test for fibrin-split products
- advise the anesthesiologist to seek additional help
- call for additional OR nursing personnel
- assign one circulator to run stats and record critical data.21-33
Prevention is the best strategy
As the opening case demonstrates, major vessel injury can occur without warning and cause cascading problems that can lead to permanent disability—even death. Because most serious vessel injuries occur during entry into the anterior abdominal wall, careful attention to entry techniques and the patient’s unique circumstances (obesity, presence of adhesions) can go a long way toward averting injury. Vigilance for the possibility of injury is also important throughout the procedure. When injury does occur, it is critical to call for help as soon as possible and to have safeguards in place to manage it.
Tune in again in October 2012 for Part 2 of this series, which offers insight into gastrointestinal and urinary tract injuries during laparoscopy and offers valuable guidance on avoiding and managing related complications.
We want to hear from you! Tell us what you think.
Failure to document treatment refusal proves costly . . . Enlarging uterus goes uninvestigated . . . more
When following CT guidelines isn’t enough
AN 86-YEAR-OLD MAN ON WARFARIN FAINTED AND FELL while baby-sitting his great-grandchildren. He had transient neurologic symptoms after collapsing but appeared normal by the time paramedics arrived. He was taken by private vehicle to the hospital, where an emergency department (ED) physician examined him. After tests for a myocardial infarction revealed normal enzymes, electrocardiogram, and chest radiograph, the patient was discharged home.
He returned to the hospital the following day and underwent a computed tomography (CT) scan, which showed a large cerebral hemorrhage. He died soon afterward.
PLAINTIFF’S CLAIM The patient should have had a CT scan during the first ED visit. A scan at that visit would have found the hemorrhage in time to save the patient’s life.
THE DEFENSE No discussion with family members about a blow to the head or head trauma occurred, and a CT scan wasn’t requested. The patient didn’t meet criteria for a head scan. Even if a scan had been done at the initial visit, it might not have revealed the bleed. Moreover, the patient’s age decreased the likelihood that earlier detection would have changed the outcome.
VERDICT Confidential Utah settlements. The hospital settled for a nominal sum early in the litigation process; the physician settled for a confidential amount immediately before trial.
COMMENT Even when clear guidelines for imaging exist, taking care to weigh extenuating circumstances—in this case, that the patient was on warfarin—is critical.
Failure to document treatment refusal proves costly
A 15-YEAR-OLD BOY lost consciousness at home on Halloween and needed cardiopulmonary resuscitation. When paramedics arrived on the scene, they found the boy conscious and breathing, so they left. The boy, who had a history of drug abuse, died 8 hours later of anoxic encephalopathy caused by cocaine and opiate intoxication.
PLAINTIFF’S CLAIM The paramedics were negligent in failing to evaluate the boy’s condition properly and transport him to a hospital.
THE DEFENSE The paramedics left without assessing the boy because he and his father said they didn’t want or need medical help. (The paramedics neglected to obtain signed refusal of treatment forms.)
VERDICT $5.1 million Illinois verdict.
COMMENT Here is a $5 million verdict that hinges on the completion of forms for refusal of treatment, a remarkable reminder of the importance of documentation.
Enlarging uterus goes uninvestigated
AT AN ANNUAL GYNECOLOGIC EXAMINATION, a woman’s physician noted that her uterus had enlarged since her last visit and described it as “top size” in the chart. At the patient’s next annual exam 21 months later, the uterus had grown to 14 weeks’ gestational size.
Ten months after that, when the woman returned to her physician complaining of abdominal discomfort, her uterus was larger than at the previous examination. The physician advised her to consider a hysterectomy.
About 2 months later, the patient went to the doctor again because of increasing pelvic pressure. Her uterus was 18 to 20 weeks’ gestational size. The physician ordered an ultrasound, which showed a large mass on each ovary and no fibroids or masses within the uterus. Magnetic resonance imaging confirmed the ultrasound findings.
The doctor referred the woman to an oncological gynecologist. She subsequently underwent an abdominal hysterectomy with bilateral salpingo-oophorectomy and bilateral periaortic lymph node dissection. The pathology report described ovarian cancer with an ominous prognosis.
PLAINTIFF’S CLAIM The plaintiff alleged that the physician was negligent for failing to order testing when he first noticed the abnormal size of the uterus and at the patient’s subsequent visits. Failure to do so at the first exam and subsequent visits was negligent and allowed the cancer to advance instead of allowing for surgery and cure at an early stage.
THE DEFENSE No information about the defense is available.
VERDICT $650,000 Maryland settlement.
COMMENT It’s never a good policy to ignore a changing physical exam without good documentation, including a clear discussion of medical decision making.
Third ED visit isn’t the charm
A 39-YEAR-OLD QUADRIPLEGIC MAN went to the emergency department (ED) complaining of abdominal pain. His history included involvement in a shooting when he was 16, drug abuse, homelessness, and frequent visits to the ED, where the staff knew him to be combative and ignore medical advice. The ED physician who saw the man ordered a radiograph and other testing, then released him without a conclusive diagnosis.
A month later, the man came back to the ED by ambulance, complaining of severe abdominal pain that he’d had for 4 days. Another ED physician saw him but didn’t make a diagnosis. After 4 hours, the hospital discharged the patient by ambulance to stay with family. When the family refused to accept him, the ambulance brought him back to the hospital.
With the involvement of social services, the patient was wheeled across the street to a motel. After about 5 hours, during which the motel staff said the patient was screaming in pain, the staff called an ambulance, which brought the man back to the ED covered with bloody vomit.
The same ED physician who had seen him earlier examined him, along with another ED physician. A fecal impaction was removed manually and a soap suds enema administered. The patient seemed to improve and, after about 7 hours, was released and rolled outside with a taxi voucher.
He said the hospital staff told him he was abusing the hospital’s services and the police would be called if he returned. He was taken to the house of a family member, where he was found dead 4 hours later from a ruptured duodenal ulcer.
PLAINTIFF’S CLAIM The physician who saw the patient at the first ED visit should have diagnosed peptic ulcer disease; the doctors who saw the man at the second and third visits should have diagnosed the ruptured ulcer. The hospital violated the federal Emergency Medical Treatment and Labor Act (EMTALA) by failing to stabilize the patient before discharging him.
THE DEFENSE The patient was stable and improving each time he was discharged. The hospital denied threatening to arrest the patient if he returned to the ED after the third visit.
VERDICT $1.4 million Kentucky verdict. The first trial ended in a mistrial. All defendants except the hospital settled for undisclosed amounts before a second trial, at which the hospital was found to be 15% at fault and a $1.5 million award for punitive damages was assessed against the hospital for violating EMTALA.
The hospital appealed and the matter was returned for trial after a ruling that affirmed everything except the punitive damages. At the third trial, a jury awarded $1.4 million in punitive damages.
COMMENT Most of us have a visceral reaction when faced with a drug abusing, noncompliant patient who frequently shows up at the ED. We must remember that such patients do get sick and that in this case, despite repeated visits to the ED, a tragedy occurred.
When following CT guidelines isn’t enough
AN 86-YEAR-OLD MAN ON WARFARIN FAINTED AND FELL while baby-sitting his great-grandchildren. He had transient neurologic symptoms after collapsing but appeared normal by the time paramedics arrived. He was taken by private vehicle to the hospital, where an emergency department (ED) physician examined him. After tests for a myocardial infarction revealed normal enzymes, electrocardiogram, and chest radiograph, the patient was discharged home.
He returned to the hospital the following day and underwent a computed tomography (CT) scan, which showed a large cerebral hemorrhage. He died soon afterward.
PLAINTIFF’S CLAIM The patient should have had a CT scan during the first ED visit. A scan at that visit would have found the hemorrhage in time to save the patient’s life.
THE DEFENSE No discussion with family members about a blow to the head or head trauma occurred, and a CT scan wasn’t requested. The patient didn’t meet criteria for a head scan. Even if a scan had been done at the initial visit, it might not have revealed the bleed. Moreover, the patient’s age decreased the likelihood that earlier detection would have changed the outcome.
VERDICT Confidential Utah settlements. The hospital settled for a nominal sum early in the litigation process; the physician settled for a confidential amount immediately before trial.
COMMENT Even when clear guidelines for imaging exist, taking care to weigh extenuating circumstances—in this case, that the patient was on warfarin—is critical.
Failure to document treatment refusal proves costly
A 15-YEAR-OLD BOY lost consciousness at home on Halloween and needed cardiopulmonary resuscitation. When paramedics arrived on the scene, they found the boy conscious and breathing, so they left. The boy, who had a history of drug abuse, died 8 hours later of anoxic encephalopathy caused by cocaine and opiate intoxication.
PLAINTIFF’S CLAIM The paramedics were negligent in failing to evaluate the boy’s condition properly and transport him to a hospital.
THE DEFENSE The paramedics left without assessing the boy because he and his father said they didn’t want or need medical help. (The paramedics neglected to obtain signed refusal of treatment forms.)
VERDICT $5.1 million Illinois verdict.
COMMENT Here is a $5 million verdict that hinges on the completion of forms for refusal of treatment, a remarkable reminder of the importance of documentation.
Enlarging uterus goes uninvestigated
AT AN ANNUAL GYNECOLOGIC EXAMINATION, a woman’s physician noted that her uterus had enlarged since her last visit and described it as “top size” in the chart. At the patient’s next annual exam 21 months later, the uterus had grown to 14 weeks’ gestational size.
Ten months after that, when the woman returned to her physician complaining of abdominal discomfort, her uterus was larger than at the previous examination. The physician advised her to consider a hysterectomy.
About 2 months later, the patient went to the doctor again because of increasing pelvic pressure. Her uterus was 18 to 20 weeks’ gestational size. The physician ordered an ultrasound, which showed a large mass on each ovary and no fibroids or masses within the uterus. Magnetic resonance imaging confirmed the ultrasound findings.
The doctor referred the woman to an oncological gynecologist. She subsequently underwent an abdominal hysterectomy with bilateral salpingo-oophorectomy and bilateral periaortic lymph node dissection. The pathology report described ovarian cancer with an ominous prognosis.
PLAINTIFF’S CLAIM The plaintiff alleged that the physician was negligent for failing to order testing when he first noticed the abnormal size of the uterus and at the patient’s subsequent visits. Failure to do so at the first exam and subsequent visits was negligent and allowed the cancer to advance instead of allowing for surgery and cure at an early stage.
THE DEFENSE No information about the defense is available.
VERDICT $650,000 Maryland settlement.
COMMENT It’s never a good policy to ignore a changing physical exam without good documentation, including a clear discussion of medical decision making.
Third ED visit isn’t the charm
A 39-YEAR-OLD QUADRIPLEGIC MAN went to the emergency department (ED) complaining of abdominal pain. His history included involvement in a shooting when he was 16, drug abuse, homelessness, and frequent visits to the ED, where the staff knew him to be combative and ignore medical advice. The ED physician who saw the man ordered a radiograph and other testing, then released him without a conclusive diagnosis.
A month later, the man came back to the ED by ambulance, complaining of severe abdominal pain that he’d had for 4 days. Another ED physician saw him but didn’t make a diagnosis. After 4 hours, the hospital discharged the patient by ambulance to stay with family. When the family refused to accept him, the ambulance brought him back to the hospital.
With the involvement of social services, the patient was wheeled across the street to a motel. After about 5 hours, during which the motel staff said the patient was screaming in pain, the staff called an ambulance, which brought the man back to the ED covered with bloody vomit.
The same ED physician who had seen him earlier examined him, along with another ED physician. A fecal impaction was removed manually and a soap suds enema administered. The patient seemed to improve and, after about 7 hours, was released and rolled outside with a taxi voucher.
He said the hospital staff told him he was abusing the hospital’s services and the police would be called if he returned. He was taken to the house of a family member, where he was found dead 4 hours later from a ruptured duodenal ulcer.
PLAINTIFF’S CLAIM The physician who saw the patient at the first ED visit should have diagnosed peptic ulcer disease; the doctors who saw the man at the second and third visits should have diagnosed the ruptured ulcer. The hospital violated the federal Emergency Medical Treatment and Labor Act (EMTALA) by failing to stabilize the patient before discharging him.
THE DEFENSE The patient was stable and improving each time he was discharged. The hospital denied threatening to arrest the patient if he returned to the ED after the third visit.
VERDICT $1.4 million Kentucky verdict. The first trial ended in a mistrial. All defendants except the hospital settled for undisclosed amounts before a second trial, at which the hospital was found to be 15% at fault and a $1.5 million award for punitive damages was assessed against the hospital for violating EMTALA.
The hospital appealed and the matter was returned for trial after a ruling that affirmed everything except the punitive damages. At the third trial, a jury awarded $1.4 million in punitive damages.
COMMENT Most of us have a visceral reaction when faced with a drug abusing, noncompliant patient who frequently shows up at the ED. We must remember that such patients do get sick and that in this case, despite repeated visits to the ED, a tragedy occurred.
When following CT guidelines isn’t enough
AN 86-YEAR-OLD MAN ON WARFARIN FAINTED AND FELL while baby-sitting his great-grandchildren. He had transient neurologic symptoms after collapsing but appeared normal by the time paramedics arrived. He was taken by private vehicle to the hospital, where an emergency department (ED) physician examined him. After tests for a myocardial infarction revealed normal enzymes, electrocardiogram, and chest radiograph, the patient was discharged home.
He returned to the hospital the following day and underwent a computed tomography (CT) scan, which showed a large cerebral hemorrhage. He died soon afterward.
PLAINTIFF’S CLAIM The patient should have had a CT scan during the first ED visit. A scan at that visit would have found the hemorrhage in time to save the patient’s life.
THE DEFENSE No discussion with family members about a blow to the head or head trauma occurred, and a CT scan wasn’t requested. The patient didn’t meet criteria for a head scan. Even if a scan had been done at the initial visit, it might not have revealed the bleed. Moreover, the patient’s age decreased the likelihood that earlier detection would have changed the outcome.
VERDICT Confidential Utah settlements. The hospital settled for a nominal sum early in the litigation process; the physician settled for a confidential amount immediately before trial.
COMMENT Even when clear guidelines for imaging exist, taking care to weigh extenuating circumstances—in this case, that the patient was on warfarin—is critical.
Failure to document treatment refusal proves costly
A 15-YEAR-OLD BOY lost consciousness at home on Halloween and needed cardiopulmonary resuscitation. When paramedics arrived on the scene, they found the boy conscious and breathing, so they left. The boy, who had a history of drug abuse, died 8 hours later of anoxic encephalopathy caused by cocaine and opiate intoxication.
PLAINTIFF’S CLAIM The paramedics were negligent in failing to evaluate the boy’s condition properly and transport him to a hospital.
THE DEFENSE The paramedics left without assessing the boy because he and his father said they didn’t want or need medical help. (The paramedics neglected to obtain signed refusal of treatment forms.)
VERDICT $5.1 million Illinois verdict.
COMMENT Here is a $5 million verdict that hinges on the completion of forms for refusal of treatment, a remarkable reminder of the importance of documentation.
Enlarging uterus goes uninvestigated
AT AN ANNUAL GYNECOLOGIC EXAMINATION, a woman’s physician noted that her uterus had enlarged since her last visit and described it as “top size” in the chart. At the patient’s next annual exam 21 months later, the uterus had grown to 14 weeks’ gestational size.
Ten months after that, when the woman returned to her physician complaining of abdominal discomfort, her uterus was larger than at the previous examination. The physician advised her to consider a hysterectomy.
About 2 months later, the patient went to the doctor again because of increasing pelvic pressure. Her uterus was 18 to 20 weeks’ gestational size. The physician ordered an ultrasound, which showed a large mass on each ovary and no fibroids or masses within the uterus. Magnetic resonance imaging confirmed the ultrasound findings.
The doctor referred the woman to an oncological gynecologist. She subsequently underwent an abdominal hysterectomy with bilateral salpingo-oophorectomy and bilateral periaortic lymph node dissection. The pathology report described ovarian cancer with an ominous prognosis.
PLAINTIFF’S CLAIM The plaintiff alleged that the physician was negligent for failing to order testing when he first noticed the abnormal size of the uterus and at the patient’s subsequent visits. Failure to do so at the first exam and subsequent visits was negligent and allowed the cancer to advance instead of allowing for surgery and cure at an early stage.
THE DEFENSE No information about the defense is available.
VERDICT $650,000 Maryland settlement.
COMMENT It’s never a good policy to ignore a changing physical exam without good documentation, including a clear discussion of medical decision making.
Third ED visit isn’t the charm
A 39-YEAR-OLD QUADRIPLEGIC MAN went to the emergency department (ED) complaining of abdominal pain. His history included involvement in a shooting when he was 16, drug abuse, homelessness, and frequent visits to the ED, where the staff knew him to be combative and ignore medical advice. The ED physician who saw the man ordered a radiograph and other testing, then released him without a conclusive diagnosis.
A month later, the man came back to the ED by ambulance, complaining of severe abdominal pain that he’d had for 4 days. Another ED physician saw him but didn’t make a diagnosis. After 4 hours, the hospital discharged the patient by ambulance to stay with family. When the family refused to accept him, the ambulance brought him back to the hospital.
With the involvement of social services, the patient was wheeled across the street to a motel. After about 5 hours, during which the motel staff said the patient was screaming in pain, the staff called an ambulance, which brought the man back to the ED covered with bloody vomit.
The same ED physician who had seen him earlier examined him, along with another ED physician. A fecal impaction was removed manually and a soap suds enema administered. The patient seemed to improve and, after about 7 hours, was released and rolled outside with a taxi voucher.
He said the hospital staff told him he was abusing the hospital’s services and the police would be called if he returned. He was taken to the house of a family member, where he was found dead 4 hours later from a ruptured duodenal ulcer.
PLAINTIFF’S CLAIM The physician who saw the patient at the first ED visit should have diagnosed peptic ulcer disease; the doctors who saw the man at the second and third visits should have diagnosed the ruptured ulcer. The hospital violated the federal Emergency Medical Treatment and Labor Act (EMTALA) by failing to stabilize the patient before discharging him.
THE DEFENSE The patient was stable and improving each time he was discharged. The hospital denied threatening to arrest the patient if he returned to the ED after the third visit.
VERDICT $1.4 million Kentucky verdict. The first trial ended in a mistrial. All defendants except the hospital settled for undisclosed amounts before a second trial, at which the hospital was found to be 15% at fault and a $1.5 million award for punitive damages was assessed against the hospital for violating EMTALA.
The hospital appealed and the matter was returned for trial after a ruling that affirmed everything except the punitive damages. At the third trial, a jury awarded $1.4 million in punitive damages.
COMMENT Most of us have a visceral reaction when faced with a drug abusing, noncompliant patient who frequently shows up at the ED. We must remember that such patients do get sick and that in this case, despite repeated visits to the ED, a tragedy occurred.
Injection may be the best bet for young athletes’ knee pain
Consider giving dextrose/lidocaine injections to adolescents with Osgood-Schlatter disease (OSD) that persists despite physical therapy.1
STRENGTH OF RECOMMENDATION
A: Based on one well-designed, randomized controlled trial (RCT).
Topol GA, Podesta LA, Reeves KD, et al. Hyperosmolar dextrose injection for recalcitrant Osgood-Schlatter disease. Pediatrics. 2011;128: e1121-e1128.
ILLUSTRATIVE CASE
A 13-year-old boy comes in to your office for follow-up of anterior knee pain from OSD that has not responded to 2 months of physical therapy. he is still unable to play on his recreational soccer team. What treatment can you offer to help him return to the sport he enjoys?
OSD is characterized by inflammation of the growth plate just below the knee, the result of repetitive strain on the secondary ossification center of the tibial tuberosity.2 Closure of the tibial growth plate is the definitive remedy for OSD, but the pain that some adolescents experience until that happens can be long-lasting and considerable. Nine years after diagnosis of OSD, one study found, up to 60% of patients who had received conservative treatment reported pain on kneeling and 18% had sports limitations.3
Inability to play may affect self-esteem
Adolescents whose recreational activities are limited due to OSD may experience a number of negative effects, including alienation from friends, altered peer group dynamics, and a decline in self-esteem. Surgery, which involves excision of the pain-producing ossicle with or without tuberculoplasty, relieves the pain and allows patients to return to their chosen sport in 90% to 95% of cases that have not responded to conservative treatment.4,5 For a self-limiting (although prolonged) condition like OSD, most physicians and patients would prefer to avoid surgery and opt for a more conservative approach.
Dextrose injections have been shown to be safe and effective when used for the treatment of tendon and ligamentous disorders such as Achilles tendonitis and lateral epicondylitis, although the mechanism of action is not clear.6,7 The study detailed in this PURL is the first prospective RCT of dextrose injections for the treatment of OSD.
STUDY SUMMARY: injections get adolescents back in the game
Topol et al1 sought to compare the efficacy of injections of dextrose and lidocaine with lidocaine-only injections or supervised usual care in treating OSD in young athletes. Sixty-six Argentinian boys and girls ages 9 to 17 years, all of whom had anterior knee pain and participated in kicking or jumping sports on organized teams, were considered for the study. The absence of either patellofemoral crepitus or proximal patellar tendon tenderness was a prerequisite for participation, as was reproduction of the anterior knee pain and localization of pain precisely to the tibial tuberosity during a single leg squat to confirm the OSD diagnosis.
After diagnosis, the patients completed ≥2 months of formal and gently progressive hamstring stretching, quads strengthening, and gradual reintroduction into their respective sports. Those who experienced pain during team play that persisted for ≥3 months—54 patients, all but 3 of whom were male, with a total of 65 knees requiring treatment—were included in the study. Participants were randomized to the usual care group or to one of the injection groups, which was blinded to patients, guardians, and physicians.
The injection groups received a solution of lidocaine 1%, alone or with 12.5% dextrose, at the start of the study and again at 1 and 2 months. Adequate injection was determined by complete pain relief during a single leg squat, which was also used to determine both proximal and distal points of tenderness. Both injection groups received 0.5-mL injections with a 27-gauge needle, repeated at approximately 1-cm intervals for a total of 3 to 4 midline injections. After 5 minutes, the leg squat was repeated to detect any remaining pain, and painful areas were injected until the patient could do a pain-free leg squat.
Because pain reduction may precede full healing, those in both the lidocaine-only and the dextrose-lidocaine groups received injections on all 3 occasions even if they were pain free. They were instructed to avoid running for a week after the initial treatment and then to run as tolerated. Subsequent treatments required a 3-day rest from running. Participants were able to return to their sport after the second injection and rest period.
Patients in all 3 groups received handouts explaining hamstring stretches and quadriceps strengthening exercises. The usual care group received individual instruction from a physical therapist. They were also given a video and returned at least once, both to ensure that they were performing the exercises correctly and to encourage compliance.
The primary outcome involved the Nirschl Pain Phase Scale (NPPS), a 7-point measure of sports-related symptoms and level of participation. Scores of 4 to 7 represent sports limitation resulting from pain. Scores <4 (which may involve soreness or pain but participation in the sport is unlimited) and 0 (asymptomatic participation) were the threshold goals for the study.
The groups were similar at baseline, and follow-up was 100%. At 3 months, NPPS scores improved more in dextrose-treated knees than in either the lidocaine-treated knees (3.9 vs 2.4; P=.004) or those who received usual care (3.9 vs 1.2; P=.001), and lidocaine alone was significantly better than usual care (2.4 vs 1.2; P=.024). More than 90% of participants in both injection groups achieved unlimited sports participation by 3 months. However, knees treated with dextrose were significantly more likely than lidocaine-treated knees to allow asymptomatic participation (NPPS=0), with 14 of 21 knees and 5 of 22 knees, respectively, being pain-free. After one year, more dextrose-treated knees than lidocaine-treated knees were asymptomatic with sports participation (32 of 38 vs 6 of 13; P=.024).
There were no reported adverse effects during this study and fewer than 10% of subjects required acetaminophen for postinjection pain control.
WHAT’S NEW: OSD can be safely and effectively treated
This study found dextrose injections to be safe, well tolerated, and effective in treating patients with intractable OSD symptoms. The results suggest that the duration of both the sports limitation and sports-related symptoms may be reduced with dextrose injections in adolescent athletes with recalcitrant OSD.
CAVEATS: Lack of validated measure, controls
NPPS is not an ideal measure of OSD symptoms because it has not been validated. The failure to use a validated measure of tendinopathy symptoms (eg, the Victorian Institute of Sport Assessment-Patella8) is a significant limitation of this trial. The athletes included in this study had already failed to respond to the usual treatment, which suggests that injections should be reserved for those who have tried hamstring stretching and quad-strengthening exercises.
CHALLENGES TO IMPLEMENTATION: Patient and provider comfort may be an issue
Although the injections in this study were well tolerated, there is a risk of infection, bleeding, and pain with any injection or invasive procedure. In addition, adolescents often have difficulty tolerating injections, especially repeated needlesticks like those called for in the proposed treatment. The nonviscous nature of dextrose allows 27- to 30-gauge needles to be used, which may make the injections easier for teens to tolerate. Some physicians may be hesitant to start these young patients on a new injectable therapy.
Click here to view PURL METHODOLOGY
1. Topol GA, Podesta LA, Reeves KD, et al. Hyperosmolar dextrose injection for recalcitrant Osgood-Schlatter disease. Pediatrics. 2011;128:e1121-e1128.
2. Gholve PA, Scher DM, Khakharia S, et al. Osgood-Schlatter syndrome. Curr Opin Pediatr. 2007;19:44-50.
3. Krause BL, Willimas JP, Caterall A. Natural history of OsgoodSchlatter disease. J Pediatr Orthop. 1990;10:65-68.
4. Nierenberg G, Falah M, Keren Y, et al. Surgical treatment of residual Osgood-Schlatter disease in young adults: role of the mobile osseous fragment. Orthopedics. 2011;34:176.-
5. El-Husseini TF, Abdelgawad AA. Results of surgical treatment of unresolved Osgood-Schlatter disease in adults. J Knee Surg. 2010;23:103-107.
6. Ryan M, Wong A, Taunton J. Favorable outcomes after sonographically guided intratendinous injection of hyperosmolar dextrose for chronic insertional and midportion achilles tendinosis. AJR Am J Roentgenol. 2010;194:1047-1053.
7. Scarpone M, Rabago D, Zgierska A, et al. The efficacy of prolotherapy for lateral epicondylitis: a pilot study. Clin J Sport Med. 2008;18:248-254.
8. Visentini PJ, Khan KM, Cook JL, et al. The VISA score: an index of severity of symptoms in patients with jumper’s knee (patellar tendinosis). Victorian Institute of Sport Tendon Study Group. J Sci Med Sport. 1998;1:22-28.
 | Young athlete sidelined? Check to see how he’s coping Samantha O’Connell, PhD |
Mark Sakr, DO
Department of Family Medicine, University of North Carolina at Chapel Hill
Anne Mounsey, MD
Department of Family Medicine, University of North Carolina at Chapel Hill
PURLs EDITOR
John Hickner, MD, MSc
Cleveland Clinic
| Young athlete sidelined? Check to see how he’s coping Samantha O’Connell, PhD |
Mark Sakr, DO
Department of Family Medicine, University of North Carolina at Chapel Hill
Anne Mounsey, MD
Department of Family Medicine, University of North Carolina at Chapel Hill
PURLs EDITOR
John Hickner, MD, MSc
Cleveland Clinic
| Young athlete sidelined? Check to see how he’s coping Samantha O’Connell, PhD |
Mark Sakr, DO
Department of Family Medicine, University of North Carolina at Chapel Hill
Anne Mounsey, MD
Department of Family Medicine, University of North Carolina at Chapel Hill
PURLs EDITOR
John Hickner, MD, MSc
Cleveland Clinic
Consider giving dextrose/lidocaine injections to adolescents with Osgood-Schlatter disease (OSD) that persists despite physical therapy.1
STRENGTH OF RECOMMENDATION
A: Based on one well-designed, randomized controlled trial (RCT).
Topol GA, Podesta LA, Reeves KD, et al. Hyperosmolar dextrose injection for recalcitrant Osgood-Schlatter disease. Pediatrics. 2011;128: e1121-e1128.
ILLUSTRATIVE CASE
A 13-year-old boy comes in to your office for follow-up of anterior knee pain from OSD that has not responded to 2 months of physical therapy. he is still unable to play on his recreational soccer team. What treatment can you offer to help him return to the sport he enjoys?
OSD is characterized by inflammation of the growth plate just below the knee, the result of repetitive strain on the secondary ossification center of the tibial tuberosity.2 Closure of the tibial growth plate is the definitive remedy for OSD, but the pain that some adolescents experience until that happens can be long-lasting and considerable. Nine years after diagnosis of OSD, one study found, up to 60% of patients who had received conservative treatment reported pain on kneeling and 18% had sports limitations.3
Inability to play may affect self-esteem
Adolescents whose recreational activities are limited due to OSD may experience a number of negative effects, including alienation from friends, altered peer group dynamics, and a decline in self-esteem. Surgery, which involves excision of the pain-producing ossicle with or without tuberculoplasty, relieves the pain and allows patients to return to their chosen sport in 90% to 95% of cases that have not responded to conservative treatment.4,5 For a self-limiting (although prolonged) condition like OSD, most physicians and patients would prefer to avoid surgery and opt for a more conservative approach.
Dextrose injections have been shown to be safe and effective when used for the treatment of tendon and ligamentous disorders such as Achilles tendonitis and lateral epicondylitis, although the mechanism of action is not clear.6,7 The study detailed in this PURL is the first prospective RCT of dextrose injections for the treatment of OSD.
STUDY SUMMARY: injections get adolescents back in the game
Topol et al1 sought to compare the efficacy of injections of dextrose and lidocaine with lidocaine-only injections or supervised usual care in treating OSD in young athletes. Sixty-six Argentinian boys and girls ages 9 to 17 years, all of whom had anterior knee pain and participated in kicking or jumping sports on organized teams, were considered for the study. The absence of either patellofemoral crepitus or proximal patellar tendon tenderness was a prerequisite for participation, as was reproduction of the anterior knee pain and localization of pain precisely to the tibial tuberosity during a single leg squat to confirm the OSD diagnosis.
After diagnosis, the patients completed ≥2 months of formal and gently progressive hamstring stretching, quads strengthening, and gradual reintroduction into their respective sports. Those who experienced pain during team play that persisted for ≥3 months—54 patients, all but 3 of whom were male, with a total of 65 knees requiring treatment—were included in the study. Participants were randomized to the usual care group or to one of the injection groups, which was blinded to patients, guardians, and physicians.
The injection groups received a solution of lidocaine 1%, alone or with 12.5% dextrose, at the start of the study and again at 1 and 2 months. Adequate injection was determined by complete pain relief during a single leg squat, which was also used to determine both proximal and distal points of tenderness. Both injection groups received 0.5-mL injections with a 27-gauge needle, repeated at approximately 1-cm intervals for a total of 3 to 4 midline injections. After 5 minutes, the leg squat was repeated to detect any remaining pain, and painful areas were injected until the patient could do a pain-free leg squat.
Because pain reduction may precede full healing, those in both the lidocaine-only and the dextrose-lidocaine groups received injections on all 3 occasions even if they were pain free. They were instructed to avoid running for a week after the initial treatment and then to run as tolerated. Subsequent treatments required a 3-day rest from running. Participants were able to return to their sport after the second injection and rest period.
Patients in all 3 groups received handouts explaining hamstring stretches and quadriceps strengthening exercises. The usual care group received individual instruction from a physical therapist. They were also given a video and returned at least once, both to ensure that they were performing the exercises correctly and to encourage compliance.
The primary outcome involved the Nirschl Pain Phase Scale (NPPS), a 7-point measure of sports-related symptoms and level of participation. Scores of 4 to 7 represent sports limitation resulting from pain. Scores <4 (which may involve soreness or pain but participation in the sport is unlimited) and 0 (asymptomatic participation) were the threshold goals for the study.
The groups were similar at baseline, and follow-up was 100%. At 3 months, NPPS scores improved more in dextrose-treated knees than in either the lidocaine-treated knees (3.9 vs 2.4; P=.004) or those who received usual care (3.9 vs 1.2; P=.001), and lidocaine alone was significantly better than usual care (2.4 vs 1.2; P=.024). More than 90% of participants in both injection groups achieved unlimited sports participation by 3 months. However, knees treated with dextrose were significantly more likely than lidocaine-treated knees to allow asymptomatic participation (NPPS=0), with 14 of 21 knees and 5 of 22 knees, respectively, being pain-free. After one year, more dextrose-treated knees than lidocaine-treated knees were asymptomatic with sports participation (32 of 38 vs 6 of 13; P=.024).
There were no reported adverse effects during this study and fewer than 10% of subjects required acetaminophen for postinjection pain control.
WHAT’S NEW: OSD can be safely and effectively treated
This study found dextrose injections to be safe, well tolerated, and effective in treating patients with intractable OSD symptoms. The results suggest that the duration of both the sports limitation and sports-related symptoms may be reduced with dextrose injections in adolescent athletes with recalcitrant OSD.
CAVEATS: Lack of validated measure, controls
NPPS is not an ideal measure of OSD symptoms because it has not been validated. The failure to use a validated measure of tendinopathy symptoms (eg, the Victorian Institute of Sport Assessment-Patella8) is a significant limitation of this trial. The athletes included in this study had already failed to respond to the usual treatment, which suggests that injections should be reserved for those who have tried hamstring stretching and quad-strengthening exercises.
CHALLENGES TO IMPLEMENTATION: Patient and provider comfort may be an issue
Although the injections in this study were well tolerated, there is a risk of infection, bleeding, and pain with any injection or invasive procedure. In addition, adolescents often have difficulty tolerating injections, especially repeated needlesticks like those called for in the proposed treatment. The nonviscous nature of dextrose allows 27- to 30-gauge needles to be used, which may make the injections easier for teens to tolerate. Some physicians may be hesitant to start these young patients on a new injectable therapy.
Click here to view PURL METHODOLOGY
Consider giving dextrose/lidocaine injections to adolescents with Osgood-Schlatter disease (OSD) that persists despite physical therapy.1
STRENGTH OF RECOMMENDATION
A: Based on one well-designed, randomized controlled trial (RCT).
Topol GA, Podesta LA, Reeves KD, et al. Hyperosmolar dextrose injection for recalcitrant Osgood-Schlatter disease. Pediatrics. 2011;128: e1121-e1128.
ILLUSTRATIVE CASE
A 13-year-old boy comes in to your office for follow-up of anterior knee pain from OSD that has not responded to 2 months of physical therapy. he is still unable to play on his recreational soccer team. What treatment can you offer to help him return to the sport he enjoys?
OSD is characterized by inflammation of the growth plate just below the knee, the result of repetitive strain on the secondary ossification center of the tibial tuberosity.2 Closure of the tibial growth plate is the definitive remedy for OSD, but the pain that some adolescents experience until that happens can be long-lasting and considerable. Nine years after diagnosis of OSD, one study found, up to 60% of patients who had received conservative treatment reported pain on kneeling and 18% had sports limitations.3
Inability to play may affect self-esteem
Adolescents whose recreational activities are limited due to OSD may experience a number of negative effects, including alienation from friends, altered peer group dynamics, and a decline in self-esteem. Surgery, which involves excision of the pain-producing ossicle with or without tuberculoplasty, relieves the pain and allows patients to return to their chosen sport in 90% to 95% of cases that have not responded to conservative treatment.4,5 For a self-limiting (although prolonged) condition like OSD, most physicians and patients would prefer to avoid surgery and opt for a more conservative approach.
Dextrose injections have been shown to be safe and effective when used for the treatment of tendon and ligamentous disorders such as Achilles tendonitis and lateral epicondylitis, although the mechanism of action is not clear.6,7 The study detailed in this PURL is the first prospective RCT of dextrose injections for the treatment of OSD.
STUDY SUMMARY: injections get adolescents back in the game
Topol et al1 sought to compare the efficacy of injections of dextrose and lidocaine with lidocaine-only injections or supervised usual care in treating OSD in young athletes. Sixty-six Argentinian boys and girls ages 9 to 17 years, all of whom had anterior knee pain and participated in kicking or jumping sports on organized teams, were considered for the study. The absence of either patellofemoral crepitus or proximal patellar tendon tenderness was a prerequisite for participation, as was reproduction of the anterior knee pain and localization of pain precisely to the tibial tuberosity during a single leg squat to confirm the OSD diagnosis.
After diagnosis, the patients completed ≥2 months of formal and gently progressive hamstring stretching, quads strengthening, and gradual reintroduction into their respective sports. Those who experienced pain during team play that persisted for ≥3 months—54 patients, all but 3 of whom were male, with a total of 65 knees requiring treatment—were included in the study. Participants were randomized to the usual care group or to one of the injection groups, which was blinded to patients, guardians, and physicians.
The injection groups received a solution of lidocaine 1%, alone or with 12.5% dextrose, at the start of the study and again at 1 and 2 months. Adequate injection was determined by complete pain relief during a single leg squat, which was also used to determine both proximal and distal points of tenderness. Both injection groups received 0.5-mL injections with a 27-gauge needle, repeated at approximately 1-cm intervals for a total of 3 to 4 midline injections. After 5 minutes, the leg squat was repeated to detect any remaining pain, and painful areas were injected until the patient could do a pain-free leg squat.
Because pain reduction may precede full healing, those in both the lidocaine-only and the dextrose-lidocaine groups received injections on all 3 occasions even if they were pain free. They were instructed to avoid running for a week after the initial treatment and then to run as tolerated. Subsequent treatments required a 3-day rest from running. Participants were able to return to their sport after the second injection and rest period.
Patients in all 3 groups received handouts explaining hamstring stretches and quadriceps strengthening exercises. The usual care group received individual instruction from a physical therapist. They were also given a video and returned at least once, both to ensure that they were performing the exercises correctly and to encourage compliance.
The primary outcome involved the Nirschl Pain Phase Scale (NPPS), a 7-point measure of sports-related symptoms and level of participation. Scores of 4 to 7 represent sports limitation resulting from pain. Scores <4 (which may involve soreness or pain but participation in the sport is unlimited) and 0 (asymptomatic participation) were the threshold goals for the study.
The groups were similar at baseline, and follow-up was 100%. At 3 months, NPPS scores improved more in dextrose-treated knees than in either the lidocaine-treated knees (3.9 vs 2.4; P=.004) or those who received usual care (3.9 vs 1.2; P=.001), and lidocaine alone was significantly better than usual care (2.4 vs 1.2; P=.024). More than 90% of participants in both injection groups achieved unlimited sports participation by 3 months. However, knees treated with dextrose were significantly more likely than lidocaine-treated knees to allow asymptomatic participation (NPPS=0), with 14 of 21 knees and 5 of 22 knees, respectively, being pain-free. After one year, more dextrose-treated knees than lidocaine-treated knees were asymptomatic with sports participation (32 of 38 vs 6 of 13; P=.024).
There were no reported adverse effects during this study and fewer than 10% of subjects required acetaminophen for postinjection pain control.
WHAT’S NEW: OSD can be safely and effectively treated
This study found dextrose injections to be safe, well tolerated, and effective in treating patients with intractable OSD symptoms. The results suggest that the duration of both the sports limitation and sports-related symptoms may be reduced with dextrose injections in adolescent athletes with recalcitrant OSD.
CAVEATS: Lack of validated measure, controls
NPPS is not an ideal measure of OSD symptoms because it has not been validated. The failure to use a validated measure of tendinopathy symptoms (eg, the Victorian Institute of Sport Assessment-Patella8) is a significant limitation of this trial. The athletes included in this study had already failed to respond to the usual treatment, which suggests that injections should be reserved for those who have tried hamstring stretching and quad-strengthening exercises.
CHALLENGES TO IMPLEMENTATION: Patient and provider comfort may be an issue
Although the injections in this study were well tolerated, there is a risk of infection, bleeding, and pain with any injection or invasive procedure. In addition, adolescents often have difficulty tolerating injections, especially repeated needlesticks like those called for in the proposed treatment. The nonviscous nature of dextrose allows 27- to 30-gauge needles to be used, which may make the injections easier for teens to tolerate. Some physicians may be hesitant to start these young patients on a new injectable therapy.
Click here to view PURL METHODOLOGY
1. Topol GA, Podesta LA, Reeves KD, et al. Hyperosmolar dextrose injection for recalcitrant Osgood-Schlatter disease. Pediatrics. 2011;128:e1121-e1128.
2. Gholve PA, Scher DM, Khakharia S, et al. Osgood-Schlatter syndrome. Curr Opin Pediatr. 2007;19:44-50.
3. Krause BL, Willimas JP, Caterall A. Natural history of OsgoodSchlatter disease. J Pediatr Orthop. 1990;10:65-68.
4. Nierenberg G, Falah M, Keren Y, et al. Surgical treatment of residual Osgood-Schlatter disease in young adults: role of the mobile osseous fragment. Orthopedics. 2011;34:176.-
5. El-Husseini TF, Abdelgawad AA. Results of surgical treatment of unresolved Osgood-Schlatter disease in adults. J Knee Surg. 2010;23:103-107.
6. Ryan M, Wong A, Taunton J. Favorable outcomes after sonographically guided intratendinous injection of hyperosmolar dextrose for chronic insertional and midportion achilles tendinosis. AJR Am J Roentgenol. 2010;194:1047-1053.
7. Scarpone M, Rabago D, Zgierska A, et al. The efficacy of prolotherapy for lateral epicondylitis: a pilot study. Clin J Sport Med. 2008;18:248-254.
8. Visentini PJ, Khan KM, Cook JL, et al. The VISA score: an index of severity of symptoms in patients with jumper’s knee (patellar tendinosis). Victorian Institute of Sport Tendon Study Group. J Sci Med Sport. 1998;1:22-28.
1. Topol GA, Podesta LA, Reeves KD, et al. Hyperosmolar dextrose injection for recalcitrant Osgood-Schlatter disease. Pediatrics. 2011;128:e1121-e1128.
2. Gholve PA, Scher DM, Khakharia S, et al. Osgood-Schlatter syndrome. Curr Opin Pediatr. 2007;19:44-50.
3. Krause BL, Willimas JP, Caterall A. Natural history of OsgoodSchlatter disease. J Pediatr Orthop. 1990;10:65-68.
4. Nierenberg G, Falah M, Keren Y, et al. Surgical treatment of residual Osgood-Schlatter disease in young adults: role of the mobile osseous fragment. Orthopedics. 2011;34:176.-
5. El-Husseini TF, Abdelgawad AA. Results of surgical treatment of unresolved Osgood-Schlatter disease in adults. J Knee Surg. 2010;23:103-107.
6. Ryan M, Wong A, Taunton J. Favorable outcomes after sonographically guided intratendinous injection of hyperosmolar dextrose for chronic insertional and midportion achilles tendinosis. AJR Am J Roentgenol. 2010;194:1047-1053.
7. Scarpone M, Rabago D, Zgierska A, et al. The efficacy of prolotherapy for lateral epicondylitis: a pilot study. Clin J Sport Med. 2008;18:248-254.
8. Visentini PJ, Khan KM, Cook JL, et al. The VISA score: an index of severity of symptoms in patients with jumper’s knee (patellar tendinosis). Victorian Institute of Sport Tendon Study Group. J Sci Med Sport. 1998;1:22-28.
Copyright © 2012 The Family Physicians Inquiries Network. All rights reserved.
Multivitamins for healthy children: What are the true benefits?
THE BENEFITS APPEAR TO BE LIMITED. It’s doubtful that multivitamin with mineral (MVM) supplementation improves IQ in healthy, low-risk children (strength of recommendation [SOR]: B, conflicting randomized clinical trials [RCTs]).
However, MVM supplementation decreased the incidence and severity of common infectious diseases among children in peri-urban India (SOR: B, RCT).
Multivitamin (MV) use doesn’t have consistently reported harms (SOR: C, conflicting cohort studies). An association between MV use and higher rates of asthma and food allergy has been reported, but studies conflict and any such effect is small.
Evidence summary
An RCT found that MVM supplementation for one academic year didn’t improve academic achievement more than placebo in 640 children, 8 to 12 years of age, from low-income urban families.1 Scores on the Terra Nova academic achievement test of reading, math, language, science, and social sciences didn’t differ between students taking MVM supplements or placebo.
Another RCT that compared MVM supplementation with placebo among 245 children between 6 and 12 years of age found no clinically significant improvements in IQ scores overall. However, within a small subset, more children who took MVM showed a clinical increase in IQ than children who took placebo.2
Investigators randomized children to daily MVM supplementation (50% of the US recommended daily allowance) or placebo for 3 months, then measured their Wechsler IQ scores. Overall, the MVM group scored 2.5 points higher (95% confidence interval [CI], 1.85-3.15) than the placebo group (a 15-point change is clinically significant).
More children taking MVM supplements (44) than placebo (25) showed increases in nonverbal IQ scores of 15 or more points (35% compared with 21%; P<.01). The authors speculate that this result may be attributable to the fact that one in 7 schoolchildren was undernourished. A major weakness of the study was its 16% attrition rate.
Fortified milk reduced disease in young children in India
A community-based, double-blind RCT found that milk fortified with vitamins A, C, and E plus minerals reduced common illnesses over the course of a year more than unfortified milk among 633 children 1 to 3 years of age living in a peri-urban area of India.3
Children who drank fortified milk had fewer days of fever (9.1 compared with 9.7 days for placebo; P=.005), a lower incidence of diarrhea (odds ratio [OR]=0.82; 95% CI, 0.73-0.93), and a decreased rate of lower respiratory illness (OR=0.74; 95% CI, 0.57-0.97). Children 2 years and younger showed the greatest effect.
Asthma and food allergies: The data are mixed
An inception cohort study found an association between early MV use and a higher risk of asthma and food allergies.4 Investigators evaluated more than 8000 American women and their newborns over the first 3 years of life. The study population included more families with low socioeconomic status (50%), blacks (51%), and infants born before 37 weeks’ gestation (23%) than the general US population.
Exclusively formula-fed infants who took MV in the first 6 months were more likely to develop asthma (OR=1.27; 95% CI, 1.04-1.56) and food allergies (OR=1.6; 95% CI, 1.2-2.2) than formula-fed infants who didn’t take MV.
However, a birth cohort study of 2470 Swedish children that analyzed health data from parental questionnaires and compared serum immunoglobulin E (IgE) concentrations at 8 years of age found no association between MV use within the past 12 months and clinical allergic disease or specific IgE concentrations.5 Children who took MV at age 4 years or earlier had lower rates of IgE sensitization to food allergens at 8 years (OR=0.61; 95% CI, 0.39-0.97).
Recommendations
According to the American Academy of Pediatrics Committee on Nutrition,6 healthy children who are growing normally and consume a varied diet don’t need routine supplementation with vitamins and minerals. The Committee states that if parents wish to give their children supplements, a standard pediatric multivitamin generally poses no risk.
1. Perlman AI, Worobey J, O‘Sullivan Maillet J, et al. Multivitamin/mineral supplementation does not affect standardized assessment of academic performance in elementary school children. J Am Diet Assoc. 2010;110:1089-1093.
2. Schoenthaler SJ, Bier ID, Young K, et al. The effect of vitamin-mineral supplementation on the intelligence of American schoolchildren: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 2000;6:19-29.
3. Sazawal S, Dhingra U, Dhingra P, et al. Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked, placebo controlled trial. BMJ. 2007;334:140.-
4. Milner JD, Stein DM, McCarter R, et al. Early infant multivitamin supplementation is associated with increased risk for food allergy and asthma. Pediatrics. 2004;114:27-32.
5. Marmsjö K, Rosenlund H, Kull I, et al. Use of multivitamin supplements in relation to allergic disease in 8-year-old children. Am J Clin Nutr. 2009;90:1693-1698.
6. Committee on Nutrition, American Academy of Pediatrics. Feeding the child. In: Kleinman RE, ed. Pediatric Nutrition Handbook. 6th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2009:145–174.
THE BENEFITS APPEAR TO BE LIMITED. It’s doubtful that multivitamin with mineral (MVM) supplementation improves IQ in healthy, low-risk children (strength of recommendation [SOR]: B, conflicting randomized clinical trials [RCTs]).
However, MVM supplementation decreased the incidence and severity of common infectious diseases among children in peri-urban India (SOR: B, RCT).
Multivitamin (MV) use doesn’t have consistently reported harms (SOR: C, conflicting cohort studies). An association between MV use and higher rates of asthma and food allergy has been reported, but studies conflict and any such effect is small.
Evidence summary
An RCT found that MVM supplementation for one academic year didn’t improve academic achievement more than placebo in 640 children, 8 to 12 years of age, from low-income urban families.1 Scores on the Terra Nova academic achievement test of reading, math, language, science, and social sciences didn’t differ between students taking MVM supplements or placebo.
Another RCT that compared MVM supplementation with placebo among 245 children between 6 and 12 years of age found no clinically significant improvements in IQ scores overall. However, within a small subset, more children who took MVM showed a clinical increase in IQ than children who took placebo.2
Investigators randomized children to daily MVM supplementation (50% of the US recommended daily allowance) or placebo for 3 months, then measured their Wechsler IQ scores. Overall, the MVM group scored 2.5 points higher (95% confidence interval [CI], 1.85-3.15) than the placebo group (a 15-point change is clinically significant).
More children taking MVM supplements (44) than placebo (25) showed increases in nonverbal IQ scores of 15 or more points (35% compared with 21%; P<.01). The authors speculate that this result may be attributable to the fact that one in 7 schoolchildren was undernourished. A major weakness of the study was its 16% attrition rate.
Fortified milk reduced disease in young children in India
A community-based, double-blind RCT found that milk fortified with vitamins A, C, and E plus minerals reduced common illnesses over the course of a year more than unfortified milk among 633 children 1 to 3 years of age living in a peri-urban area of India.3
Children who drank fortified milk had fewer days of fever (9.1 compared with 9.7 days for placebo; P=.005), a lower incidence of diarrhea (odds ratio [OR]=0.82; 95% CI, 0.73-0.93), and a decreased rate of lower respiratory illness (OR=0.74; 95% CI, 0.57-0.97). Children 2 years and younger showed the greatest effect.
Asthma and food allergies: The data are mixed
An inception cohort study found an association between early MV use and a higher risk of asthma and food allergies.4 Investigators evaluated more than 8000 American women and their newborns over the first 3 years of life. The study population included more families with low socioeconomic status (50%), blacks (51%), and infants born before 37 weeks’ gestation (23%) than the general US population.
Exclusively formula-fed infants who took MV in the first 6 months were more likely to develop asthma (OR=1.27; 95% CI, 1.04-1.56) and food allergies (OR=1.6; 95% CI, 1.2-2.2) than formula-fed infants who didn’t take MV.
However, a birth cohort study of 2470 Swedish children that analyzed health data from parental questionnaires and compared serum immunoglobulin E (IgE) concentrations at 8 years of age found no association between MV use within the past 12 months and clinical allergic disease or specific IgE concentrations.5 Children who took MV at age 4 years or earlier had lower rates of IgE sensitization to food allergens at 8 years (OR=0.61; 95% CI, 0.39-0.97).
Recommendations
According to the American Academy of Pediatrics Committee on Nutrition,6 healthy children who are growing normally and consume a varied diet don’t need routine supplementation with vitamins and minerals. The Committee states that if parents wish to give their children supplements, a standard pediatric multivitamin generally poses no risk.
THE BENEFITS APPEAR TO BE LIMITED. It’s doubtful that multivitamin with mineral (MVM) supplementation improves IQ in healthy, low-risk children (strength of recommendation [SOR]: B, conflicting randomized clinical trials [RCTs]).
However, MVM supplementation decreased the incidence and severity of common infectious diseases among children in peri-urban India (SOR: B, RCT).
Multivitamin (MV) use doesn’t have consistently reported harms (SOR: C, conflicting cohort studies). An association between MV use and higher rates of asthma and food allergy has been reported, but studies conflict and any such effect is small.
Evidence summary
An RCT found that MVM supplementation for one academic year didn’t improve academic achievement more than placebo in 640 children, 8 to 12 years of age, from low-income urban families.1 Scores on the Terra Nova academic achievement test of reading, math, language, science, and social sciences didn’t differ between students taking MVM supplements or placebo.
Another RCT that compared MVM supplementation with placebo among 245 children between 6 and 12 years of age found no clinically significant improvements in IQ scores overall. However, within a small subset, more children who took MVM showed a clinical increase in IQ than children who took placebo.2
Investigators randomized children to daily MVM supplementation (50% of the US recommended daily allowance) or placebo for 3 months, then measured their Wechsler IQ scores. Overall, the MVM group scored 2.5 points higher (95% confidence interval [CI], 1.85-3.15) than the placebo group (a 15-point change is clinically significant).
More children taking MVM supplements (44) than placebo (25) showed increases in nonverbal IQ scores of 15 or more points (35% compared with 21%; P<.01). The authors speculate that this result may be attributable to the fact that one in 7 schoolchildren was undernourished. A major weakness of the study was its 16% attrition rate.
Fortified milk reduced disease in young children in India
A community-based, double-blind RCT found that milk fortified with vitamins A, C, and E plus minerals reduced common illnesses over the course of a year more than unfortified milk among 633 children 1 to 3 years of age living in a peri-urban area of India.3
Children who drank fortified milk had fewer days of fever (9.1 compared with 9.7 days for placebo; P=.005), a lower incidence of diarrhea (odds ratio [OR]=0.82; 95% CI, 0.73-0.93), and a decreased rate of lower respiratory illness (OR=0.74; 95% CI, 0.57-0.97). Children 2 years and younger showed the greatest effect.
Asthma and food allergies: The data are mixed
An inception cohort study found an association between early MV use and a higher risk of asthma and food allergies.4 Investigators evaluated more than 8000 American women and their newborns over the first 3 years of life. The study population included more families with low socioeconomic status (50%), blacks (51%), and infants born before 37 weeks’ gestation (23%) than the general US population.
Exclusively formula-fed infants who took MV in the first 6 months were more likely to develop asthma (OR=1.27; 95% CI, 1.04-1.56) and food allergies (OR=1.6; 95% CI, 1.2-2.2) than formula-fed infants who didn’t take MV.
However, a birth cohort study of 2470 Swedish children that analyzed health data from parental questionnaires and compared serum immunoglobulin E (IgE) concentrations at 8 years of age found no association between MV use within the past 12 months and clinical allergic disease or specific IgE concentrations.5 Children who took MV at age 4 years or earlier had lower rates of IgE sensitization to food allergens at 8 years (OR=0.61; 95% CI, 0.39-0.97).
Recommendations
According to the American Academy of Pediatrics Committee on Nutrition,6 healthy children who are growing normally and consume a varied diet don’t need routine supplementation with vitamins and minerals. The Committee states that if parents wish to give their children supplements, a standard pediatric multivitamin generally poses no risk.
1. Perlman AI, Worobey J, O‘Sullivan Maillet J, et al. Multivitamin/mineral supplementation does not affect standardized assessment of academic performance in elementary school children. J Am Diet Assoc. 2010;110:1089-1093.
2. Schoenthaler SJ, Bier ID, Young K, et al. The effect of vitamin-mineral supplementation on the intelligence of American schoolchildren: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 2000;6:19-29.
3. Sazawal S, Dhingra U, Dhingra P, et al. Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked, placebo controlled trial. BMJ. 2007;334:140.-
4. Milner JD, Stein DM, McCarter R, et al. Early infant multivitamin supplementation is associated with increased risk for food allergy and asthma. Pediatrics. 2004;114:27-32.
5. Marmsjö K, Rosenlund H, Kull I, et al. Use of multivitamin supplements in relation to allergic disease in 8-year-old children. Am J Clin Nutr. 2009;90:1693-1698.
6. Committee on Nutrition, American Academy of Pediatrics. Feeding the child. In: Kleinman RE, ed. Pediatric Nutrition Handbook. 6th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2009:145–174.
1. Perlman AI, Worobey J, O‘Sullivan Maillet J, et al. Multivitamin/mineral supplementation does not affect standardized assessment of academic performance in elementary school children. J Am Diet Assoc. 2010;110:1089-1093.
2. Schoenthaler SJ, Bier ID, Young K, et al. The effect of vitamin-mineral supplementation on the intelligence of American schoolchildren: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 2000;6:19-29.
3. Sazawal S, Dhingra U, Dhingra P, et al. Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked, placebo controlled trial. BMJ. 2007;334:140.-
4. Milner JD, Stein DM, McCarter R, et al. Early infant multivitamin supplementation is associated with increased risk for food allergy and asthma. Pediatrics. 2004;114:27-32.
5. Marmsjö K, Rosenlund H, Kull I, et al. Use of multivitamin supplements in relation to allergic disease in 8-year-old children. Am J Clin Nutr. 2009;90:1693-1698.
6. Committee on Nutrition, American Academy of Pediatrics. Feeding the child. In: Kleinman RE, ed. Pediatric Nutrition Handbook. 6th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2009:145–174.
Evidence-based answers from the Family Physicians Inquiries Network
Do inhaled steroids reduce bone mineral density and increase fracture risk?
NO, except perhaps at high doses. Inhaled corticosteroids (ICS) at low to medium doses (<1500 mcg beclomethasone hydrofluoroalkane per day) for asthma and chronic obstructive pulmonary disease (COPD) don’t increase the risk of significant bone loss or fracture at 2 to 3 years follow-up (strength of recommendation [SOR]: A, systematic reviews and randomize controlled trials [RCTs]). Higher doses, however, may raise the risk of nontraumatic fracture over 1 to 4 years of follow-up (SOR: B, case control studies).
Experts recommend using the lowest effective dose to mitigate potential bone risks (SOR: C, expert consensus).
Evidence summary
A 2008 Cochrane review examined 7 RCTs comparing ICS with placebo in 1989 patients 30 to 52 years of age with mild asthma or COPD. The reviewers found no evidence of increased bone turnover, decreased bone mineral density, or increased vertebral fracture in the ICS group compared with the placebo group at 2 to 3 years’ follow-up (odds ratio [OR] for fracture=1.87; 95% confidence interval [CI], 0.5-7.0).
Steroid doses ranged from 200 to 4000 mcg beclomethasone equivalent ICS per day.1 A 100-mcg beclomethasone equivalent ICS dose is 50 mcg fluticasone, 80 mcg budesonide, or 200 mcg triamcinolone.2
A 2008 meta-analysis of 11 RCTs that examined a number of adverse effects of ICS in adult patients with COPD found 3 studies (8131 patients) that reported no significant increase in fracture risk at 36 months in the ICS group compared with the placebo group (OR=1.09; 95% CI, 0.89-1.33). Steroid doses ranged from 1000 to 2000 mcg beclomethasone equivalent ICS per day.3
Some studies suggest an association between dose and risk
A 2008 meta-analysis that included patients with COPD or asthma, average age 43 to 81 years, showed no difference in fracture risk overall at 1 to 4 years’ follow-up (OR=1.02; 95% CI, 0.96-1.08). This analysis examined 4 RCTs, 6 case-control studies, and 3 cohort studies.4
A subgroup analysis of patients taking higher-dose ICS (>1500 mcg beclomethasone equivalent ICS per day) that pooled data from case-control and cohort studies suggested an increased risk of fracture (OR=1.30; 95% CI, 1.07-1.58).4
Investigators identified a possible dose-dependent relationship in another meta-analysis of 5 case-control studies (43,783 cases, 259,936 controls).5 The meta-analysis included 4 of the studies examined in the previously discussed meta-analysis.4
The investigators found a relative risk of 1.12 (95% CI, 1.0-1.26) for nonvertebral fracture for each 1000-mcg increase in beclomethasone equivalent ICS dose per day.5 Longer follow-up time wasn’t associated with greater fracture risk.
But the relationship isn’t clear
Although some non-RCT studies discussed here show that higher doses of steroids may lead to increased fracture risk, the strength of this association isn’t clear. The authors of the Cochrane review and the meta-analyses point out that a significant number of confounding factors can put asthma and COPD patients at increased risk for fracture. They include age, smoking status, inactivity, and severity of underlying lung disease. The fact that different authors controlled differently for these factors introduced heterogeneity into the meta-analyses described here.1,3-5
Recommendations
Guidelines for the Diagnosis and Management of Asthma from the National Heart, Lung, and Blood Institute state that “most benefit is achieved with relatively low doses of ICS, whereas the risk of adverse effects increases with dose. … ICS use may be associated with a dose-dependent reduction in bone mineral content, although low or medium doses appear to have no major adverse effect. Elderly patients may be more at risk due to preexisting osteoporosis, changes in estrogen levels that affect calcium utilization, and a sedentary lifestyle.”6
1. Jones A, Fay JK, Burr M, et al. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2008;(4):CD003537.-
2. Gonelli S, Caffarelli C, Maggi S, et al. Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study. Calcif Tissue Int. 2010;87:137-143.
3. Drummond MB, Dasenbrook EC, Pitz MW, et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008;300:2407-2416.
4. Etminan M, Sadatsafavi M, Ganjizadeh Zavareh S, et al. Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis. Drug Saf. 2008;31:409-414.
5. Weatherall M, James K, Clay J, et al. Dose-response relationship for risk of nonvertebral fracture with inhaled corticosteroids. Clin Exp Allergy. 2008;38:1451-1458.
6. National Heart Lung and Blood Institute. Expert Panel Report 3 (EPR3): guidelines for the diagnosis and management of asthma. Available at: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed February 25, 2012.
NO, except perhaps at high doses. Inhaled corticosteroids (ICS) at low to medium doses (<1500 mcg beclomethasone hydrofluoroalkane per day) for asthma and chronic obstructive pulmonary disease (COPD) don’t increase the risk of significant bone loss or fracture at 2 to 3 years follow-up (strength of recommendation [SOR]: A, systematic reviews and randomize controlled trials [RCTs]). Higher doses, however, may raise the risk of nontraumatic fracture over 1 to 4 years of follow-up (SOR: B, case control studies).
Experts recommend using the lowest effective dose to mitigate potential bone risks (SOR: C, expert consensus).
Evidence summary
A 2008 Cochrane review examined 7 RCTs comparing ICS with placebo in 1989 patients 30 to 52 years of age with mild asthma or COPD. The reviewers found no evidence of increased bone turnover, decreased bone mineral density, or increased vertebral fracture in the ICS group compared with the placebo group at 2 to 3 years’ follow-up (odds ratio [OR] for fracture=1.87; 95% confidence interval [CI], 0.5-7.0).
Steroid doses ranged from 200 to 4000 mcg beclomethasone equivalent ICS per day.1 A 100-mcg beclomethasone equivalent ICS dose is 50 mcg fluticasone, 80 mcg budesonide, or 200 mcg triamcinolone.2
A 2008 meta-analysis of 11 RCTs that examined a number of adverse effects of ICS in adult patients with COPD found 3 studies (8131 patients) that reported no significant increase in fracture risk at 36 months in the ICS group compared with the placebo group (OR=1.09; 95% CI, 0.89-1.33). Steroid doses ranged from 1000 to 2000 mcg beclomethasone equivalent ICS per day.3
Some studies suggest an association between dose and risk
A 2008 meta-analysis that included patients with COPD or asthma, average age 43 to 81 years, showed no difference in fracture risk overall at 1 to 4 years’ follow-up (OR=1.02; 95% CI, 0.96-1.08). This analysis examined 4 RCTs, 6 case-control studies, and 3 cohort studies.4
A subgroup analysis of patients taking higher-dose ICS (>1500 mcg beclomethasone equivalent ICS per day) that pooled data from case-control and cohort studies suggested an increased risk of fracture (OR=1.30; 95% CI, 1.07-1.58).4
Investigators identified a possible dose-dependent relationship in another meta-analysis of 5 case-control studies (43,783 cases, 259,936 controls).5 The meta-analysis included 4 of the studies examined in the previously discussed meta-analysis.4
The investigators found a relative risk of 1.12 (95% CI, 1.0-1.26) for nonvertebral fracture for each 1000-mcg increase in beclomethasone equivalent ICS dose per day.5 Longer follow-up time wasn’t associated with greater fracture risk.
But the relationship isn’t clear
Although some non-RCT studies discussed here show that higher doses of steroids may lead to increased fracture risk, the strength of this association isn’t clear. The authors of the Cochrane review and the meta-analyses point out that a significant number of confounding factors can put asthma and COPD patients at increased risk for fracture. They include age, smoking status, inactivity, and severity of underlying lung disease. The fact that different authors controlled differently for these factors introduced heterogeneity into the meta-analyses described here.1,3-5
Recommendations
Guidelines for the Diagnosis and Management of Asthma from the National Heart, Lung, and Blood Institute state that “most benefit is achieved with relatively low doses of ICS, whereas the risk of adverse effects increases with dose. … ICS use may be associated with a dose-dependent reduction in bone mineral content, although low or medium doses appear to have no major adverse effect. Elderly patients may be more at risk due to preexisting osteoporosis, changes in estrogen levels that affect calcium utilization, and a sedentary lifestyle.”6
NO, except perhaps at high doses. Inhaled corticosteroids (ICS) at low to medium doses (<1500 mcg beclomethasone hydrofluoroalkane per day) for asthma and chronic obstructive pulmonary disease (COPD) don’t increase the risk of significant bone loss or fracture at 2 to 3 years follow-up (strength of recommendation [SOR]: A, systematic reviews and randomize controlled trials [RCTs]). Higher doses, however, may raise the risk of nontraumatic fracture over 1 to 4 years of follow-up (SOR: B, case control studies).
Experts recommend using the lowest effective dose to mitigate potential bone risks (SOR: C, expert consensus).
Evidence summary
A 2008 Cochrane review examined 7 RCTs comparing ICS with placebo in 1989 patients 30 to 52 years of age with mild asthma or COPD. The reviewers found no evidence of increased bone turnover, decreased bone mineral density, or increased vertebral fracture in the ICS group compared with the placebo group at 2 to 3 years’ follow-up (odds ratio [OR] for fracture=1.87; 95% confidence interval [CI], 0.5-7.0).
Steroid doses ranged from 200 to 4000 mcg beclomethasone equivalent ICS per day.1 A 100-mcg beclomethasone equivalent ICS dose is 50 mcg fluticasone, 80 mcg budesonide, or 200 mcg triamcinolone.2
A 2008 meta-analysis of 11 RCTs that examined a number of adverse effects of ICS in adult patients with COPD found 3 studies (8131 patients) that reported no significant increase in fracture risk at 36 months in the ICS group compared with the placebo group (OR=1.09; 95% CI, 0.89-1.33). Steroid doses ranged from 1000 to 2000 mcg beclomethasone equivalent ICS per day.3
Some studies suggest an association between dose and risk
A 2008 meta-analysis that included patients with COPD or asthma, average age 43 to 81 years, showed no difference in fracture risk overall at 1 to 4 years’ follow-up (OR=1.02; 95% CI, 0.96-1.08). This analysis examined 4 RCTs, 6 case-control studies, and 3 cohort studies.4
A subgroup analysis of patients taking higher-dose ICS (>1500 mcg beclomethasone equivalent ICS per day) that pooled data from case-control and cohort studies suggested an increased risk of fracture (OR=1.30; 95% CI, 1.07-1.58).4
Investigators identified a possible dose-dependent relationship in another meta-analysis of 5 case-control studies (43,783 cases, 259,936 controls).5 The meta-analysis included 4 of the studies examined in the previously discussed meta-analysis.4
The investigators found a relative risk of 1.12 (95% CI, 1.0-1.26) for nonvertebral fracture for each 1000-mcg increase in beclomethasone equivalent ICS dose per day.5 Longer follow-up time wasn’t associated with greater fracture risk.
But the relationship isn’t clear
Although some non-RCT studies discussed here show that higher doses of steroids may lead to increased fracture risk, the strength of this association isn’t clear. The authors of the Cochrane review and the meta-analyses point out that a significant number of confounding factors can put asthma and COPD patients at increased risk for fracture. They include age, smoking status, inactivity, and severity of underlying lung disease. The fact that different authors controlled differently for these factors introduced heterogeneity into the meta-analyses described here.1,3-5
Recommendations
Guidelines for the Diagnosis and Management of Asthma from the National Heart, Lung, and Blood Institute state that “most benefit is achieved with relatively low doses of ICS, whereas the risk of adverse effects increases with dose. … ICS use may be associated with a dose-dependent reduction in bone mineral content, although low or medium doses appear to have no major adverse effect. Elderly patients may be more at risk due to preexisting osteoporosis, changes in estrogen levels that affect calcium utilization, and a sedentary lifestyle.”6
1. Jones A, Fay JK, Burr M, et al. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2008;(4):CD003537.-
2. Gonelli S, Caffarelli C, Maggi S, et al. Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study. Calcif Tissue Int. 2010;87:137-143.
3. Drummond MB, Dasenbrook EC, Pitz MW, et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008;300:2407-2416.
4. Etminan M, Sadatsafavi M, Ganjizadeh Zavareh S, et al. Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis. Drug Saf. 2008;31:409-414.
5. Weatherall M, James K, Clay J, et al. Dose-response relationship for risk of nonvertebral fracture with inhaled corticosteroids. Clin Exp Allergy. 2008;38:1451-1458.
6. National Heart Lung and Blood Institute. Expert Panel Report 3 (EPR3): guidelines for the diagnosis and management of asthma. Available at: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed February 25, 2012.
1. Jones A, Fay JK, Burr M, et al. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2008;(4):CD003537.-
2. Gonelli S, Caffarelli C, Maggi S, et al. Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study. Calcif Tissue Int. 2010;87:137-143.
3. Drummond MB, Dasenbrook EC, Pitz MW, et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008;300:2407-2416.
4. Etminan M, Sadatsafavi M, Ganjizadeh Zavareh S, et al. Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis. Drug Saf. 2008;31:409-414.
5. Weatherall M, James K, Clay J, et al. Dose-response relationship for risk of nonvertebral fracture with inhaled corticosteroids. Clin Exp Allergy. 2008;38:1451-1458.
6. National Heart Lung and Blood Institute. Expert Panel Report 3 (EPR3): guidelines for the diagnosis and management of asthma. Available at: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed February 25, 2012.
Evidence-based answers from the Family Physicians Inquiries Network